<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Brain</journal-id>
<journal-title-group>
<journal-title>Molecular Brain</journal-title>
</journal-title-group>
<issn pub-type="epub">1756-6606</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26419846</article-id>
<article-id pub-id-type="pmc">4589208</article-id>
<article-id pub-id-type="publisher-id">146</article-id>
<article-id pub-id-type="doi">10.1186/s13041-015-0146-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lim</surname>
<given-names>Chae-Seok</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Jung-eun</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>You-Kyung</given-names>
</name>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Kyungmin</given-names>
</name>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lee</surname>
<given-names>Jin-A</given-names>
</name>
<address>
<email>leeja@hnu.kr</email>
</address>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kaang</surname>
<given-names>Bong-Kiun</given-names>
</name>
<address>
<email>kaang@snu.ac.kr</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><label></label>Department of Biological Sciences, College of Natural Sciences, Seoul National University, Gwanangno 599, Seoul, Gwanak-gu 151-747 Korea </aff>
<aff id="Aff2"><label></label>Department of Biological Sciences and Biotechnology, College of Life Science and NanoTechnology, Hannam University, Jeonmin-dong 461-6, Daejeon, Yuseong-gu 305-811 Korea </aff>
<aff id="Aff3"><label></label>Department of Anatomy, Kyungpook National University Graduate School of Medicine, Dongin-dong 2-101, Daegu, Jung-gu 700-422 Korea </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>30</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>30</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>8</volume>
<elocation-id>57</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>5</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>9</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© Lim et al. 2015</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by deficits in social cognition, language development, and repetitive/restricted behaviors. Due to the complexity and heterogeneity of ASD and lack of a proper human cellular model system, the pathophysiological mechanism of ASD during the developmental process is largely unknown. However, recent progress in induced pluripotent stem cell (iPSC) technology as well as <italic>in vitro</italic> neural differentiation techniques have allowed us to functionally characterize neurons and analyze cortical development during neural differentiation. These technical advances will increase our understanding of the pathogenic mechanisms of heterogeneous ASD and help identify molecular biomarkers for patient stratification as well as personalized medicine. In this review, we summarize our current knowledge of iPSC generation, differentiation of specific neuronal subtypes from iPSCs, and phenotypic characterizations of human ASD patient-derived iPSC models. Finally, we discuss the current limitations of iPSC technology and future directions of ASD pathophysiology studies using iPSCs.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Autism spectrum disorder (ASD)</kwd>
<kwd>Cellular reprogramming</kwd>
<kwd>Induced pluripotent stem cells (iPSCs)</kwd>
<kwd>Neural differentiation</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2015</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="intro">
<title>Introduction</title>
<p>Autism spectrum disorder (ASD), which is characterized, in varying degrees, by difficulties in social interactions, verbal and nonverbal communications, and by repetitive behaviors, is complex disorders of brain development. The prevalence of ASD is estimated to range between ~25 and ~110 per 10,000 children [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. There are no available cures for this devastating disease despite several current clinical trials. ASD is known to be highly heritable, as indicated by a study of monozygotic twins with a 70–90 % concordance rate. In addition to its strong heritability, recent genetic studies have shown that ASD has hundreds of candidate genes with many different putatively disruptive variants [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. However, these are relatively rare genetic variations, each of which accounts for less than 1 % of ASD cases [<xref ref-type="bibr" rid="CR5">5</xref>]. Furthermore, ASD-associated genetic variations occur <italic>de novo</italic> in affected individuals and are sometimes inherited from normal parents, indicating either incomplete penetrance or other genetic modifications. Current studies have focused on the identification of common cellular pathways in order to account for connections between these various ASD candidate genes. Interestingly, to date, many synaptic proteins have been identified as ASD candidate genes, making it possible to study ASD pathogenesis using cellular and animal models [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR9">9</xref>].</p>
<p>To understand the underlying pathophysiological mechanisms of ASD, murine models have been generated using ASD candidate genes, including synaptic genes [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. However, murine models are not always feasible and have several limitations for studying human neurodevelopment. Heterozygous mice with ASD mutation rarely develop ASD phenotypes unless the ASD genetic mutation is homozygous, which is exceptionally rare in ASD cases, indicating that other genetic modifications are required for developing ASD phenotypes or candidate genes have different functions in human neurons [<xref ref-type="bibr" rid="CR13">13</xref>]. Furthermore, some human neocortical regions affected in ASD are not obtainable from mouse brain tissue, and brain development of mice does not perfectly reflect typical development of the human brain. Thus, understanding of neurodevelopmental disorders such as ASD has been lagged in the studies using animal models, including rodents or primate [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Although primate models can overcome the limitations of rodent models such as differences in brain anatomy, response to drugs, or circuit connectivity between human and rodent brains, they recapitulate only limited behaviors such as simple social interactions or repetitive behaviors. Primate models could be difficult to apply for representation of a variety of human complex behavioral alterations shown in ASD patients to understand associated biological mechanisms and develop a knowledge-based therapy for ASD [<xref ref-type="bibr" rid="CR15">15</xref>]. Although <italic>in vitro</italic> studies on neural differentiation using human embryonic stem cells (ESCs) have been suggested for understanding of human neurodevelopment, there remain numerous practical or ethical issues [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p>
<p>To overcome these obstacles, induced pluripotent stem cells (iPSCs) technology, which allows the generation of personalized human neurons from ASD patients, has been used for studying the pathophysiology of ASD [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR20">20</xref>]. In this case, human neurodevelopment, which cannot be addressed in an animal model <italic>in vitro</italic> or <italic>in vivo</italic>, can be tracked using personalized iPSCs from ASD patients under an individual genetic background. Moreover, current gene engineering technology for human iPSCs using sequence-specific designed zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALENs), or CRISPR/Cas-9 has made disruption, mutation, or deletion of even large genomic fragments possible at a specific locus in the genome of hiPSCs and can be applied in ASD research for generation of isogenic iPSCs with gene correction and genetic disruption [<xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR26">26</xref>]. In addition, as an alternative method for customized disease modeling, direct conversion methods from human somatic cells into desired cell types such as neurons using lineage-specific factors have been suggested [<xref ref-type="bibr" rid="CR27">27</xref>–<xref ref-type="bibr" rid="CR29">29</xref>], although this method is still challenging and further stabilizing steps are needed for standardization of protocols.</p>
<p>In this review, we summarize (1) recent advances in generation of iPSCs, (2) current methods of neural differentiation from iPSCs, and (3) functional characterization of cellular disease phenotypes using recent ASD iPSC models and then discuss current limitations, future directions for modeling of ASD using iPSC technology, and potential applications [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR30">30</xref>].</p>
</sec>
<sec id="Sec2">
<title>Generation of iPSCs from human somatic cells: cellular reprogramming</title>
<p>In 2006–2007, Takahashi and Yamanaka first showed that retroviral transfer of four transcription factors (Oct4, Sox2, Klf4, and c-Myc) known as Yamanaka’s factors is sufficient for cellular reprogramming of mouse or human skin fibroblasts into stem-cell like cells known as iPSCs, which have self-renewability and pluripotency [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Although there are concerns about subtle differences in transcriptomes, proteomes, and epigenomes between ESCs and iPSCs, iPSCs have been used in diverse research areas and clinical trials such as disease modeling, drug discovery, toxicology test, and regenerative medicine [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR33">33</xref>] (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). In recent years, iPSC reprogramming technology has undergone considerable improvements to overcome inefficient protocols and ensure functional derivatives for clinical application. Recent developments in iPSC technology using various somatic cell types include improved reprogramming methods using novel delivery systems such as non-integrating viral and non-viral vectors as well as identification of alternative reprogramming factors or small molecules such as inhibitors of specific signaling or epigenetic modulators, which replace conventional reprogramming factors and facilitate reprogramming processes [<xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR35">35</xref>] (Table <xref ref-type="table" rid="Tab2">2</xref>). A number of studies have reported detailed protocols for iPSC generation [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Here, we summarize recent trends for generation of iPSCs from human somatic cells.<fig id="Fig1"><label>Fig. 1</label><caption><p>Generation and application of patient-specific iPSCs. Patient-specific iPSCs have been generated from human somatic cells such as skin fibroblasts or peripheral blood cells by viral, non-viral delivery, or chemical induction method. These customized iPSCs have been differentiated into desired neuronal cell types such as neurons, astrocytes, or microglia. Furthermore, iPSC-derived EB (embryoid body) could develop 3D cerebral organoids, which can recapitulate human cortical development. Therefore, patient-specific iPSC-derived neural cells or cerebral organoids could be used for diverse applications for disease modeling, drug discovery, toxicology test, and regenerative medicine</p></caption><graphic id="MO1" xlink:href="13041_2015_146_Fig1_HTML"></graphic></fig></p>
<sec id="Sec3">
<title>Sources of somatic cells for reprogramming</title>
<p>The first step in iPSC generation is obtaining appropriate human somatic cells from patient tissues [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>] after an accurate diagnosis of disease based on valid clinical processes. However, unlike other genetic or non-psychiatric disorders, the examiners should be far more careful when diagnosing ASD, including autism. Clinicians can usually consider two different categories of behavioral tests for the diagnosis of autistic individuals, observational reports (including questionnaires) such as the Autism Diagnostic Observation Schedule (ADOS) [<xref ref-type="bibr" rid="CR39">39</xref>], Autism Diagnostic Interview-Revised (ADI-R) [<xref ref-type="bibr" rid="CR40">40</xref>], Clinical Global Impression (CGI) Scale [<xref ref-type="bibr" rid="CR41">41</xref>], Childhood Autism Rating Scale (CARS) [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], Autism Behavior Checklist (ABC) [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>] and Social Responsiveness Scale (SRS) [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>] and the results of an aptitude test such as the Wechsler Adult Intelligence Scale (WAIS) [<xref ref-type="bibr" rid="CR48">48</xref>] (Table <xref ref-type="table" rid="Tab1">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Behavioral tests for the diagnosis of autistic individuals</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Test methods</th><th>Description</th><th>References</th></tr></thead><tbody><tr><td rowspan="6">Observational report (including questionnaires)</td><td>Autism Diagnostic Observation Schedule (ADOS)</td><td>A standardized assessment in terms of objective evaluation of autistic social and communicative behavior symptoms</td><td>Lord et al. 1989 [<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td>Autism Diagnostic Interview-Revised (ADI-R)</td><td>An interview conducted with the parents of autistic individual to cover autistic individual’s full developmental history</td><td>Lord et al. 1994 [<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td>Clinical Global Impression (CGI) Scale</td><td>A three-item scale used to assess treatment response in patients with mental disorders</td><td>Guy 1976 [<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td>Childhood Autism Rating Scale (CARS)</td><td>A score calculated by subjective observation of a child’s behavior across fifteen criteria</td><td>Schopler et al. 1980 [<xref ref-type="bibr" rid="CR42">42</xref>]; Mayes et al. 2012 [<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td>Autism Behavior Checklist (ABC)</td><td>A 57-checklist of behavioral characteristics, which has been used for diagnosis of autism</td><td>Krug et al. 1980 [<xref ref-type="bibr" rid="CR44">44</xref>]; Volkmar et al. 1988 [<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td>Social Responsiveness Scale (SRS)</td><td>A quantitative measure of autistic traits completed by a caregiver familiar with the autistic individuals within 4–18 year olds</td><td>Constantino 2002 [<xref ref-type="bibr" rid="CR46">46</xref>]; Aldridge et al. 2012 [<xref ref-type="bibr" rid="CR47">47</xref>]</td></tr><tr><td>Aptitude test</td><td>Wechsler Adult Intelligence Scale (WAIS)</td><td>A form of IQ test designed to measure intelligence in adults and older adolescents, which has separate verbal and non-verbal IQ scores</td><td>Wechsler 1939 [<xref ref-type="bibr" rid="CR48">48</xref>]</td></tr></tbody></table></table-wrap></p>
<p>The most common cell type as the starting material for reprogramming process is skin dermal fibroblasts [<xref ref-type="bibr" rid="CR38">38</xref>]. However, since it is difficult to obtain skin biopsies from young children, especially those with autistic behavior, and the skin biopsy method using a punch is an invasive approach, it is important to obtain donor cells with high reprogramming capacity in a non-invasive way. As an alternative common cell source, peripheral blood cells are used for cellular reprogramming due to their non-invasive, easy, and routine accessibility in a clinic setting [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. Recent efforts in iPSC generation have attempted to develop exfoliated renal epithelial cells from urine, buccal cells, cord blood-derived cells, or keratinocytes from hair cells as cell sources for reprogramming despite concerns about purification method, culture stability for long-term passaging, reproducibility, and efficiency for reprogramming [<xref ref-type="bibr" rid="CR38">38</xref>]. Future advances in iPSC technology using human somatic cell types with easier access and handling, higher efficiency, and cost-effectiveness for successful reprogramming will allow development of more common customized medicines using iPSCs.</p>
</sec>
<sec id="Sec4">
<title>Induction methods for cellular reprogramming: integrative/non-integrative</title>
<p>Once somatic cells are taken from biopsies and cultured enough passages, they can be induced into stem cells using an appropriate reprogramming method. Many kinds of induction methods for cellular reprogramming have been reported depending on the delivery system of reprogramming factors or types of factors (ex, small molecules, inhibitors, etc.) as alternative reprogramming inducers [<xref ref-type="bibr" rid="CR33">33</xref>]. The most common method is the introduction of reprogramming factors into somatic cells via an integrating or non-integrating delivery system [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>].</p>
<sec id="Sec5">
<title>Integrating delivery system: retroviral/lentiviral vectors</title>
<p>Integrating methods use viral vectors such as retroviral or lentiviral vectors with high efficiency of gene delivery, although viral vectors integrate into the host cell genome (reprogramming efficiency: ~0.01–0.1 %). Generally, reprogramming factors are silenced after cellular reprogramming. However, genomic integration using viral vectors could induce reactivation of these genes, raising the possibility of oncogenesis in iPSC–derived cells or silencing of other functional genes after cellular reprogramming [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. Thus, many reprogramming methods without genomic integration have been described as a non-integrating approach, and some are commonly used for generation of iPSCs [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR52">52</xref>].</p>
</sec>
<sec id="Sec6">
<title>Non-integrating delivery system</title>
<p>Regarding non-integrating approaches, non-integrating viral vectors (Sendai or Adeno virus), episomal vector, piggy BAC vector, Cre-inducible/excisable lentiviral vector, minicircle DNA, poly-arginine-tagged polypeptide (protein), RNA-modified synthetic mRNA, or microRNAs have been suggested for iPSC generation with diverse ranges of reprogramming efficiency (reprogramming efficiency: 0.001 ~ 4 %) [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR55">55</xref>–<xref ref-type="bibr" rid="CR65">65</xref>]. Although each method has pros and cons (Table <xref ref-type="table" rid="Tab2">2</xref>), non-integrating approaches generally have lower efficiency of cellular reprogramming compared to integrating lenti- or retroviral vectors. However, many efforts have attempted to improve the efficiency of cellular reprogramming.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Comparisons of reprogramming delivery system</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Delivery system</th><th>Pros</th><th>Cons</th><th>References</th></tr></thead><tbody><tr><td rowspan="2">Integrating method</td><td>Retrovirus</td><td>High reprogramming efficiency (~0.01–0.1 %)</td><td>Possibility of oncogenesis; silencing of functional genes</td><td>Takahashi and Yamanaka. 2006 [<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td>Lentivirus</td><td>High reprogramming efficiency (~0.01–0.1 %)</td><td>Possibility of oncogenesis; silencing of functional genes</td><td>Yu et al. 2007 [<xref ref-type="bibr" rid="CR51">51</xref>]</td></tr><tr><td rowspan="9">Non-integrating method</td><td>Sendai virus</td><td>No risk of altering the host genome; high reprogramming efficiency(~1 %); easy to select iPSCs</td><td>Stringent steps to remove the reprogrammed cells of replicating virus; sensitivity of the viral RNA replicase</td><td>Fusaki et al. 2009 [<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td>Adenovirus</td><td>Transient, high-level expression</td><td>Low reprogramming efficiency (0.0001-0.001 %); possibility of small pieces insertion of adenoviral DNA; 3 out of 13(or approximately 23 %) were tetraploid</td><td>Stadtfeld et al. 2008 [<xref ref-type="bibr" rid="CR56">56</xref>]</td></tr><tr><td>OriP/EBNA-based episomal vector</td><td>Unnecessary for viral packaging; gradual loss of cellular EV without drug selection; relatively high reprogramming efficiency of IRES2-mediated expression(~0.1 %); further addition of c-Myc and Klf4 improve the reprogramming efficiency to over 1 %</td><td>Unstable transfection efficiency</td><td>Yu et al. 2009 [<xref ref-type="bibr" rid="CR168">168</xref>]</td></tr><tr><td>Piggy BAC transposons</td><td>Technical simplification (use of effortless plasmid DNA preparation and commercial transfection products); no limited range of somatic cell types for reprogramming; allow the option of xeno-free hiPSC production; accurate transgene removal through transposase expression</td><td>Labor intensive removal of multiple transposons; more CNVs in early passage than in intermediate passage;</td><td>Woltjen et al. 2009 [<xref ref-type="bibr" rid="CR59">59</xref>]; Hussein et al. 2011 [<xref ref-type="bibr" rid="CR162">162</xref>]</td></tr><tr><td>Cre-inducible/excisable lentivirus</td><td>Minimize the risk of chromosomal translocations; improve the developmental potential and differentiation capacity</td><td>Inefficient delivery of Cre; difficult to detect successful Cre-recombeniation; result in mosaic colonies; leaves 200 bp of exogenous DNA</td><td>Sommer et al. 2010 [<xref ref-type="bibr" rid="CR58">58</xref>]; Soldner et al. 2009 [<xref ref-type="bibr" rid="CR169">169</xref>]; Papapetrou et al. 2011 [<xref ref-type="bibr" rid="CR170">170</xref>]</td></tr><tr><td>Minicircle DNA</td><td>Free of foreign or chemical elements; requiring only a single vector without the need for subsequent drug selection, vector excision, or the inclusion of oncogenes; FAD approved</td><td>Low reprogramming efficiency (~0.005 %)</td><td>Jia et al. 2010 [<xref ref-type="bibr" rid="CR73">73</xref>]; Narsinh et al. 2011 [<xref ref-type="bibr" rid="CR75">75</xref>]</td></tr><tr><td>Poly-arginine-tagged polypeptide</td><td>No risk of altering the host genome; simpler and faster approach than the genetic method</td><td>Low reprogramming efficiency (~0.006 %); requires either chemical treatment or greater than four rounds of treatment; expertise in protein chemistry and handling</td><td>Zhou et al. 2009 [<xref ref-type="bibr" rid="CR171">171</xref>]; Kim et al. 2009 [<xref ref-type="bibr" rid="CR60">60</xref>]</td></tr><tr><td>RNA-modified synthetic mRNA</td><td>Avoid the endogenous antiviral cell defense; high efficiency of over 2 %; resultant iPSC colonies emerge as early as 17 days</td><td>Labor intensive repeated transfection</td><td>Warren et al. 2010 [<xref ref-type="bibr" rid="CR61">61</xref>]</td></tr><tr><td></td><td>Non-immunogenic; cost-effective; easily handled;</td><td>Relatively low and inconsistent efficiency</td><td>Hou et al. 2013 [<xref ref-type="bibr" rid="CR80">80</xref>]</td></tr></tbody></table></table-wrap><list list-type="order"><list-item><p>Non-integrating transgene systems: Sendaiviral/Adenoviral vector, episomal vector, integrative but excisable system (piggy Bac, Cre-loxP), and minicircle DNA<list list-type="bullet"><list-item><label></label><p>As one of the most attractive non-integrating viral vectors, Sendai virus with a negative-sense single-stranded RNA has been suggested as a potential clinical candidate since replication of transgenes occurs in the cytoplasm without possible genomic integration [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. Although adenoviral vectors for cellular reprogramming have also been suggested as a non-integrating delivery system due to their transient and high expression of transgenes, reprogramming efficiency of human somatic cells is too low for common use (~0.0002 %) [<xref ref-type="bibr" rid="CR68">68</xref>]. For transient expression of reprogramming factors, compared to previous episomal vectors, more advanced OriP/EBNA-based episomal vectors delivering combinational transgenes such as OCT3/4, SOX2, KLF4, L-MYC, LIN28, and shRNA for p53 have been described as a promising non-integrating approach for successful iPSC generation with acceptable reprogramming efficiency [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. Generation of integration-free iPSCs using either piggy Bac transposon or the Cre-loxP system has been also successful. Both systems are known to remove integrating transgenes from iPSCs after reprogramming, although there is a small risk of gene breaks near the insertion site [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Recently, minicircle DNA, which is a novel compact vector free of bacterial DNAs or human artificial chromosomes (HACs) with capacity for large gene insertion and stable episomal maintenance, have been used to successfully generate iPSCs, although their low reprogramming efficiency should be improved [<xref ref-type="bibr" rid="CR72">72</xref>–<xref ref-type="bibr" rid="CR75">75</xref>].</p></list-item></list></p></list-item><list-item><p>Non-integrating transgene-free systems: modified mRNA, protein, and chemicals<list list-type="bullet"><list-item><label></label><p>As for other transgene-free systems, modified mRNA, microRNA, or protein has been suggested as an attractive method for iPSC reprogramming in a clinical application due to more direct delivery of reprogramming factors without genomic integration. Synthetic mRNAs modified to avoid the endogenous antiviral cell defense system have more efficiently generated iPSCs with higher efficiency and faster iPSC induction compared to the retroviral system. However, labor-intensive steps such as repeated transfections of mRNAs should be improved. Reprogramming using microRNAs has also been successful with higher efficiency [<xref ref-type="bibr" rid="CR62">62</xref>]. The protein transduction method using cell penetrating peptides is one of the safest methods for generating foot-print free iPSCs for use in a clinical purpose although reprogramming efficiency is very low (~0.0001 %) [<xref ref-type="bibr" rid="CR60">60</xref>]. In this system, technical challenges include generation of a large amount of functionally active and stable proteins as well as induction of reprogramming from diverse types of somatic cell sources via penetrating reprogramming proteins with simple treatment [<xref ref-type="bibr" rid="CR76">76</xref>].</p></list-item><list-item><label></label><p>Alternatively, diverse chemical compounds capable of replacing initial Yamanaka’s factors or other reprogramming factors have been investigated for iPSC generation due to their non-immunogenic, cost-effective, ease of use, reversible, cell-permeable, and standardized properties despite their inconsistent and low reprogramming efficiency. Small molecules that target signaling pathways such as transforming growth factor β (TGFβ) or epigenetic factors such as histone deacetylase have been proposed to generate iPSCs and improve reprogramming efficiency [<xref ref-type="bibr" rid="CR76">76</xref>–<xref ref-type="bibr" rid="CR79">79</xref>]. More recently, a cocktail of chemical compounds without any genetic factors successfully induced iPSCs from mouse somatic cells, raising the possibility of its application in the generation of iPSCs from human somatic cells [<xref ref-type="bibr" rid="CR80">80</xref>]. More intensive screening for small molecules for cellular reprogramming and optimization is needed for efficient iPSC generation and its suitable application.</p></list-item><list-item><label></label><p>As mentioned above, a variety of promising methods with advantages and disadvantages have been proposed for the generation of patient-specific iPSCs (Table <xref ref-type="table" rid="Tab2">2</xref>). Recent systematic evaluation of the most widely used techniques (Sendai-viral, episomal, or transfection of mRNA methods) for generating transgene-free hiPSCs have shown that significant differences between methods include aneuploidy rates, reprogramming efficiency, reliability, and workload, although they all result in high-quality iPSCs [<xref ref-type="bibr" rid="CR81">81</xref>]. iPSC technology is rapidly advancing toward a transgene-free, small-molecule-based approach using diverse types of human somatic cells. Choice of reprogramming method will depend on the specific purposes for one’s own iPSC research. For basic research or drug/toxicology tests using iPSCs, reprogramming methods generating iPSCs such as cost-effective integrating/nonintergrating methods with higher efficiency could be selected based on reprogramming efficiency, workload, time or economic feasibility, regardless of its safety issues. However, for clinical applications using iPSCs, safety issues such as caner progression, purity, or accessibility and feasibility using patient samples would be the most important concerns influencing selection of reprogramming methods, which would be nonintegrating/transgene-free methods.</p></list-item></list></p></list-item></list></p>
</sec>
</sec>
</sec>
<sec id="Sec7">
<title>Generation of iPSC-derived neurons: neural differentiation</title>
<p>In disease modeling using patient-specific iPSCs, the most important step is to differentiate iPSCs into desired cell types with high purity. Accumulating research on vertebrate neural development has enabled us to generate specific subtypes of human neurons or glial cells from human pluripotent stem cells (PSCs) by regulating developmentally relevant signaling pathways. During embryonic development, the neural plate (embryonic neuroectoderm) is firstly specified to the forebrain, subsequently to the midbrain/hindbrain, and then to the spinal cord by caudalization signals that include retinoic acid (RA). Similarly, human PSCs can be directed to differentiate into forebrain-like neurons by inhibiting Wingless/Int proteins (Wnt) and bone morphogenic protein (BMP) signaling [<xref ref-type="bibr" rid="CR82">82</xref>], midbrain/hindbrain by sonic hedgehog (SHH) and fibroblast growth factor 8 (FGF8) treatment [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>], and spinal cord by the action of RA <italic>in vitro</italic> [<xref ref-type="bibr" rid="CR75">85</xref>, <xref ref-type="bibr" rid="CR76">86</xref>].</p>
<sec id="Sec8">
<title>Two-dimensional neural differentiation</title>
<p>For disease modeling using iPSC-derived neurons, specific subtypes of neurons differentiated from iPSCs should be carefully chosen since the affected cell types and brain areas are different. A variety of subtype-specific neural differentiation protocols have been developed based on embryonic developmental studies. There are three general methods currently used for neural induction: (i) through embryoid body (EB) formation [<xref ref-type="bibr" rid="CR85">85</xref>–<xref ref-type="bibr" rid="CR90">90</xref>], (ii) cultivation on stromal (or mesenchymal) feeder cells [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>], and (iii) direct conversion into neural lineage by lineage-specific factors [<xref ref-type="bibr" rid="CR93">93</xref>–<xref ref-type="bibr" rid="CR97">97</xref>] or small molecules [<xref ref-type="bibr" rid="CR98">98</xref>–<xref ref-type="bibr" rid="CR100">100</xref>] (Fig. <xref ref-type="fig" rid="Fig2">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Neural differentiation from iPSCs. To study the pathophysiology of ASD using iPSCs-derived neurons, iPSCs need to be differentiated into the disease-relevant neuronal subtype such as cortical neurons. There are general methods currently used for neural induction through embryoid body (EB) formation, cultivation on stromal feeder cells, direct differentiation of iPSCs into neural lineage by lineage specific factors such as <italic>Ngn2</italic> or <italic>NeuroD1</italic>, or direct conversion of somatic cells into neurons by expression of BAM factors and/or microRNAs</p></caption><graphic id="MO2" xlink:href="13041_2015_146_Fig2_HTML"></graphic></fig></p>
<sec id="Sec9">
<title>EB-dependent differentiation</title>
<p><italic>In vivo</italic> neural tissue is differentiated from a germ layer called the ectoderm. Similarly, stem cells <italic>in vitro</italic> can develop three germ layers within aggregates called EBs, including ectoderm under appropriate stimulating conditions. Neural induction of stem cells can be commenced via EB formation by low basic fibroblast growth factor (bFGF) and subsequent induction of EBs into neural rosettes, which are a polarized organization of neuroepithelial cells and neural differentiation is achieved by a combination of specific sets of morphogens such as Wnt, SHH, BMPs, RA, and FGFs [<xref ref-type="bibr" rid="CR85">85</xref>–<xref ref-type="bibr" rid="CR88">88</xref>, <xref ref-type="bibr" rid="CR101">101</xref>–<xref ref-type="bibr" rid="CR103">103</xref>]. Motor neurons having spinal lateral column phenotypes and midbrain dopaminergic neurons were differentiated from hESCs or hiPSCs with the EB formation method [<xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]. Most <italic>in vitro</italic> ASD-related disease modeling has been used this method (Table <xref ref-type="table" rid="Tab3">3</xref>). For example, GABA (γ-amino butyric acid) and vGlut1 (vesicular glutamate transpoter-1)-positive neurons were differentiated through EB formation [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR105">105</xref>] and by blocking the BMP pathway [<xref ref-type="bibr" rid="CR106">106</xref>] in <italic>in vitro</italic> Rett syndrome modeling. In addition, Dolmetsch group used this method to obtain vGlut1/2-, GAD65/67-positive and lower cortical layer-enriched neurons from syndrome patient-derived iPSC for investigation of Timothy syndrome [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. Tuj1-, MAP2- or GFAP-positive cells from Fragile-X syndrome patient-derived iPSCs [<xref ref-type="bibr" rid="CR99">109</xref>, <xref ref-type="bibr" rid="CR110">110</xref>] and Tuj1-positive cells from Angelman syndrome patient-derived iPSCs [<xref ref-type="bibr" rid="CR111">111</xref>] were also differentiated with this method. <italic>In vitro</italic> neuronal induction through EB formation, however, is time-consuming and requires multiple steps for generation of neural epithelial cells, neuronal progenitors, neuronal differentiation, and synaptic connection and maturation. Furthermore, it is hard to obtain a homogenous population of desired neuronal subtypes with high purity due to the difficulty in controlling specific lineage differentiation from EBs [<xref ref-type="bibr" rid="CR102">112</xref>]. Therefore, the general neural induction method from EB formation was recently modified to improve induction efficiency and purity of desired neuronal cell types as well as reduce multiple steps for neural induction, although the neural induction method through EBs <italic>in vitro</italic> is ideal to mimic <italic>in vivo</italic> neural induction and neuronal differentiation. For example, inhibition of TGFβ and BMP pathways (dual SMAD inhibition: noggin and SB431542) have been used for efficient neural induction from stem cells without an EB formation step [<xref ref-type="bibr" rid="CR113">113</xref>–<xref ref-type="bibr" rid="CR116">116</xref>]. For in vitro modeling of Phelan-Mcdermid syndrome, Dolmetsch group used this method, with some modifications, to generate cortical neurons [<xref ref-type="bibr" rid="CR117">117</xref>] (Table <xref ref-type="table" rid="Tab3">3</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Phenotypic analyses of ASD iPSC-derived neurons : Rett, Phelan-Mcdermid, Timothy, Fragile-X, and Angelman Syndromes</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Diseases</th><th>Related genes</th><th>Neural differentiation methods</th><th>Identity of neurons</th><th>Electrophysiological proterties</th><th>Neurodevelopmental phenotypes</th><th>References</th></tr></thead><tbody><tr><td>Rett syndrome</td><td>Methyl CpG binding protein 2 (MECP2)</td><td>Embryoid body formation</td><td>Gluramatergic &amp; gabaergic neurons</td><td>Reduced sEPSC and sIPSC</td><td>Fewer synaptic conracts; reduced cell soma size and dendritic branching and spine density</td><td>Marchetto et al. 2010 [<xref ref-type="bibr" rid="CR104">104</xref>]; Cheung et al. 2011 [<xref ref-type="bibr" rid="CR105">105</xref>]; Kim et al. 2011 [<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td>Phelan-McDermid Syndrome (PMDS) (22q13 deletion syndrome)</td><td>Shank3</td><td>Dual smad inhibition</td><td>Forebrain neurons</td><td>Reduced excitatory synaptic transmission</td><td>Reduced glutamatergic receptors; decreased number of synapses</td><td>Shcheglovitov et al. 2013 [<xref ref-type="bibr" rid="CR117">117</xref>]</td></tr><tr><td>Timothy syndrome (A member of the long QT syndromes)</td><td>CACNA1 (alpha-1 subunit of the L-type calcium channel CaV1.2)</td><td>Embryoid body formation</td><td>Cortical-enriched neuronal populations</td><td>Increase in the sustained intracellular calcium rise following membrane depolarization; wider action potentials</td><td>Decreased expression of lower corticallayers-related genes; increases in TH (tyrosine hydroxylase)-, norepinephrine- and dopamine-positice cells; activity-dependent dendrite retraction</td><td>Pasca et al. 2011 [<xref ref-type="bibr" rid="CR107">107</xref>]; Krey et al. 2013 [<xref ref-type="bibr" rid="CR108">108</xref>]</td></tr><tr><td>Fragile X syndrome</td><td>Fragile X mental retardation 1 (FMR1)</td><td>Embryoid body formation</td><td>Tuj1-, MAP2- or GFAP-positive cells</td><td>Poor spontaneous synaptic activity and no glutamate reactivity</td><td>Reduced neurite numbers and neurite lengths; reduced PSD95 protein expression and reduced synaptic punctadensity; poor neuronal maturation and high gliogenic development</td><td>Sheridan et al. 2011 [<xref ref-type="bibr" rid="CR109">109</xref>]; Telias et al. 2013 [<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td>Angelman syndrome</td><td>Ubiquitin protein ligase E3A (UBE3A)</td><td>Embryoid body formation</td><td>Tuj1-positive cells</td><td>Normal electrophysiological properties</td><td>Intact imprinting of UBE3A</td><td>Chamberlain et al. 2010 [<xref ref-type="bibr" rid="CR111">111</xref>]</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec10">
<title>Cultivation on stromal (or mesenchymal) feeder cells</title>
<p>As the other neural induction method, stromal feeder-based differentiation system, which is a serum-free system without the use of either RA or EBs, has been widely used, although the molecular basis of the neural-inducing activity of stromal cells remains unclear [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR92">92</xref>]. An initial study suggested that stromal cells induce midbrain neuronal fate by default [<xref ref-type="bibr" rid="CR91">91</xref>].</p>
</sec>
<sec id="Sec11">
<title>Direct conversion: somatic or pluripotent stem cells to neurons/somatic cells to neural progenitor or neural stem cells</title>
<p>The other approach to generate human neurons is to convert human stem cells or somatic cells directly into neurons by defined specific factors [<xref ref-type="bibr" rid="CR93">93</xref>–<xref ref-type="bibr" rid="CR96">96</xref>] or small molecules [<xref ref-type="bibr" rid="CR98">98</xref>–<xref ref-type="bibr" rid="CR100">100</xref>]. Wernig’s group reported a simpler and direct neural conversion method from human PSCs by forced expression of only a single transcription factor, <italic>Neurogenin 2</italic> (<italic>Ngn2</italic>), <italic>NeuroD1</italic> [<xref ref-type="bibr" rid="CR97">97</xref>] or <italic>ASCL1</italic> [<xref ref-type="bibr" rid="CR118">118</xref>]. In human neurons induced via this method, functional synapses are rapidly formed within only 2 weeks after neural induction so that the time required to obtain mature human neurons <italic>in vitro</italic> is significantly reduced. Moreover, the most attractive point of using this method is to obtain a homogeneous cell population (~100 % of cortical neurons) differentiated from hESCs and hiPSCs [<xref ref-type="bibr" rid="CR97">97</xref>]. As an alternative approach to generate induced neurons, a combination of three transcription factors - <italic>BRN2</italic> (also called <italic>Pou3f2</italic>), <italic>ASCL1</italic> (also known as <italic>MASH1</italic>), and <italic>MYT1L</italic> (so called BAM factors) - could convert adult mouse fibroblasts directly into functional neurons without iPSC generation [<xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR119">119</xref>]. The neurons generated by this method are also able to fire spontaneous action potentials and make functional synapses within as early as 2 weeks after induction <italic>in vitro</italic>. The same three transcription factors also could differentiate human stem cells and fibroblasts into neurons when combined with a transcription factor, <italic>NeuroD1</italic> [<xref ref-type="bibr" rid="CR94">94</xref>], microRNAs [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR120">120</xref>], or small molecules [<xref ref-type="bibr" rid="CR121">121</xref>]. In addition, very recently, it has been reported that only small-molecule cocktails were sufficient to directly convert mouse and human fibroblasts to functional neurons without exogenous genetic factors [<xref ref-type="bibr" rid="CR98">98</xref>–<xref ref-type="bibr" rid="CR100">100</xref>]. Likewise, rapid generation of specific subtypes of neurons directly from somatic cells makes this method an effective strategy for <italic>in vitro</italic> ASD modeling. However, a key limitation of this method is that a large number of fibroblasts might be required for reliable experiments due to their low reprogramming efficiency (at most 10–30 %), and skin biopsy cannot be conducted many times on a single patient. Therefore, in some cases, it would be desirable to convert fibroblasts into self-renewing multipotent neural progenitor cells (NPCs) or neural stem cells (NSCs), which enables us to overcome the limitations associated with low reprogramming efficiency and thereby perform high-throughput drug screening. Kim et al. [<xref ref-type="bibr" rid="CR122">122</xref>] described the generation of NPCs from mouse fibroblasts by transient expression of Yamanaka’s factors (Oct4, Sox2, Klf4, and c-Myc), followed by culturing in neural induction media. However, NPCs generated by this method could be expanded for only a few passages. Thier et al. [<xref ref-type="bibr" rid="CR123">123</xref>] have generated induced NSCs with the same classical factors (Oct4, Sox2, Klf4 and c-Myc) by strictly limiting Oct4 expression and optimizing culture conditions. In addition, forced expression of four transcription factors (BRN4/Pou3f4, SOX2, KLF4 and c-MYC) [<xref ref-type="bibr" rid="CR124">124</xref>] or even a single transcription factor SOX2 [<xref ref-type="bibr" rid="CR125">125</xref>] could also directly convert mouse or human fibroblasts into NSCs without generating a pluripotent cell state. Therefore, this direct conversion method is considered a promising method for preventing teratoma formation, which is a disadvantage of iPSCs for regenerative medicine, as well as for greatly improving low conversion efficiency from fibroblasts to neurons [<xref ref-type="bibr" rid="CR126">126</xref>].</p>
<p>To study the pathophysiology of ASD using iPSC-derived neurons <italic>in vitro</italic>, it is important to obtain desired homogeneous neurons associated with ASD, as mentioned above. Cortical neurons have been suggested to be appropriate cell types since potential mechanisms underlying ASD include defects in cortical connectivity and neural migration to the cerebral cortex [<xref ref-type="bibr" rid="CR127">127</xref>]. Moreover, despite the heterogeneity of ASD, common pathways involved in synaptic development and plasticity have been proposed to be deregulated in ASD. Thus, to study developmental synaptopathy in ASD, among several protocols for neural induction, rapid generation of human cortical neurons using defined factors could be one of the best strategies for <italic>in vitro</italic> ASD modeling due to their high induction efficiency of homogenous neuronal subtype and short induction time. However, if human neurons are directly generated from stem cells or somatic cells for modeling neurodevelopmental disorders such as ASD, it might be difficult to detect developmental phenotypes during neural differentiation. Furthermore, continuous forced expression of defined factors could also mask disease phenotypes [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR128">128</xref>]. Therefore, differentiation efficiency or stability of human neurons induced by defined factors should be improved, and comparable systematic analysis of neuronal properties such as gene expression, electrical properties, or synaptic connections in human neurons differentiated either through EB formation or by defined factors needs to be carried out.</p>
</sec>
</sec>
<sec id="Sec12">
<title>Three-dimensional neural differentiation: cerebral organoids</title>
<p>Magnetic resonance imaging (MRI) studies and postmortem analysis of individual patients with ASD have consistently demonstrated anatomical abnormalities in several brain regions, which cannot be recapitulated by two-dimensional (2D) iPSC-derived neuronal culture [<xref ref-type="bibr" rid="CR129">129</xref>]. An iPSC-derived three-dimensional (3D) culture system termed cerebral organoid has been developed [<xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR131">131</xref>]. Cerebral organoids, which develop through intrinsic self-organizing properties, can be generated from EBs grown initially in ESC medium with low bFGF and Rho kinase (ROCK) inhibitor [<xref ref-type="bibr" rid="CR131">131</xref>], and they have been shown to recapitulate the complex interplay of different regions and structures of the brain [<xref ref-type="bibr" rid="CR130">130</xref>]. Therefore, 3D cerebral organoids derived from ASD patient-specific iPSCs would be the best <italic>in vitro</italic> model to uncover defects in cortical connectivity and neuronal migration of ASD. Indeed, Mariani et al. recently generated idiopathic ASD patient’s iPSC-derived brain organoids and showed increased production of inhibitory neurons by increased FOXG1 gene expression [<xref ref-type="bibr" rid="CR132">132</xref>]. However, more standardized protocols need to be developed, and further characterization and identification of neuronal cell types in specific regions of cerebral organoids should be carried out to study cortical development and for disease modeling of ASD patients.</p>
</sec>
</sec>
<sec id="Sec13">
<title>Analyses of human iPSC-derived neurons</title>
<p>To use iPSC technology in modeling of various neurodevelopmental disorders including ASD <italic>in vitro</italic>, it is important to characterize disease phenotypes in disease-specific iPSC-derived neurons and validate well-known disease phenotypes to determine whether or not iPSC-derived cellular disease models could recapitulate disease phenotypes in mouse models and human patients. Because of this reason, ASD research using this technology primarily includes several studies on monogenic cases, such as Rett Syndrome, Fragile X Syndrome, and Timothy Syndrome [<xref ref-type="bibr" rid="CR104">104</xref>–<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR134">134</xref>]. However, these initial studies on cellular disease phenotypes in iPSC-derived neurons from monogenic cases of ASD could be directed towards the identification of disease-relevant cellular characterization in both monogenic and idiopathic forms of ASD with high heterogeneity. In this section, we describe what phenotypic analyses of human iPSC-derived neurons can be performed to characterize and validate iPSC-derived cellular disease models.</p>
<p>There are general phenotypic analyses of human neurons derived from iPSCs based on (i) neural differentiation and neuronal morphologies (neurite outgrowth, synapse structure), (ii) electrophysiological properties (basic electrical properties, synaptic properties), and (iii) gene expression network (transcriptome analysis) (Fig. <xref ref-type="fig" rid="Fig3">3</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Phenotypic analyses of iPSC-derived neurons. Patient-specific iPSCs are generated from human somatic cells. After characterization, expansion, and stabilization of iPSCs, ASD patient-derived human neurons are induced. These differentiated neurons can be characterized by changes in neuronal differentiation, morphological properties, electrophysiological properties, or gene expression network to elucidate molecular pathogenic mechanisms associated with ASD such as synaptopathy</p></caption><graphic id="MO3" xlink:href="13041_2015_146_Fig3_HTML"></graphic></fig></p>
<sec id="Sec14">
<title>Neural differentiation and neuronal morphologies: neurite outgrowth/synapse structure</title>
<p>Fully differentiated neuronal cells have a distinct morphology, including distinct polarity, and extend one axon and dendritic arbors from their cell body. Therefore, the earliest phenotypes of hiPSC-derived neurons are morphological changes such as neural differentiation, neurite/axon/dendritic growth (number or length of neurite process), and synapse formation, which can be used for analysis of disease-relevant morphological phenotypic changes. During the early stages of neurogenesis, newborn neurons are NeuN-positive [<xref ref-type="bibr" rid="CR135">135</xref>] and PSA-NCAM-positive [<xref ref-type="bibr" rid="CR136">136</xref>]. These markers, together with neuronal cytoskeletal proteins Tuj1, Tau, and MAP2, can be used for measuring neural maturation efficiency or morphological changes in ASD iPSC-derived neurons [<xref ref-type="bibr" rid="CR137">137</xref>]. Specific neuronal gene expression as a subtype-specific marker can be also used to confirm neuronal identities. For example, glutamatergic neurons can express vGlut1 and vGlut2 [<xref ref-type="bibr" rid="CR138">138</xref>], GABAergic neurons express GAD65/67 [<xref ref-type="bibr" rid="CR139">139</xref>], and mature dopaminergic neurons express tyrosine hydroxylase (TH) [<xref ref-type="bibr" rid="CR140">140</xref>].</p>
<p>Moreover, disease phenotypes such as cortical connectivity and neural migration in ASD-derived cerebral organoids would be characterized using various markers for a specific subtype of neurons in cortical regions. In rodents, cortical glutamatergic neurons can be defined by their expression of different transcription factors [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR141">141</xref>–<xref ref-type="bibr" rid="CR148">148</xref>]. Layer 6 corticothalamic projection neurons are <italic>Tbr1</italic>-positive [<xref ref-type="bibr" rid="CR144">144</xref>, <xref ref-type="bibr" rid="CR145">145</xref>], layer 5 subcortical projection neurons are <italic>Ctip2</italic>-positive [<xref ref-type="bibr" rid="CR143">143</xref>], layers 2–4 neurons are <italic>Cux1/2</italic>-positive [<xref ref-type="bibr" rid="CR146">146</xref>], and layers 2–4 callosal projection neurons are <italic>Satb2</italic>-positive [<xref ref-type="bibr" rid="CR147">147</xref>, <xref ref-type="bibr" rid="CR148">148</xref>].</p>
</sec>
<sec id="Sec15">
<title>Electrophysiological properties</title>
<p>Electrophysiological characterization for basic electrical properties such as membrane potential, generation of action potentials by current injection, and synaptic properties such as appearance of spontaneous synaptic events can be applied to verify and characterize hiPSC-derived neurons. As neurons mature, resting membrane potentials (V<sub>m</sub>) become negative (more hyperpolarized) and capacitance (C<sub>m</sub>) increases due to increased branch numbers, leading to increased cell volume. In contrast, input resistance (R<sub>i</sub>) decreases as channel protein expression increases. In addition, action potential-like responses induced by depolarization are resemble the mature shape of the action potential. Since neurons are able to make synapses with other neurons, synaptic properties could be also characterized as a cellular phenotype in iPSC-derived disease models. hiPSC-derived neurons from many syndromic ASD patients have defects in synaptic connectivity such as spontaneous excitatory and inhibitory currents [<xref ref-type="bibr" rid="CR104">104</xref>], AMPA/NMDA current ratio [<xref ref-type="bibr" rid="CR117">117</xref>], as well as intrinsic neuronal excitability [<xref ref-type="bibr" rid="CR107">107</xref>] (Table <xref ref-type="table" rid="Tab3">3</xref>).</p>
</sec>
<sec id="Sec16">
<title>Gene expression network</title>
<p>Similar to the phenotypic analyses, transcriptional changes based on gene expression network could be characterized in ASD iPSC-derived neurons. This analysis based on a systems biology approach allows us to understand alterations of the gene network involved in neural development and functions associated with ASD. Recent studies using genome-wide weighted co-expression network analysis (GWCNA) on Timothy Syndrome (TS)-derived neural cells have shown that altered Ca<sup>2+</sup> signaling in TS patients leads to dysregulation of calcium-dependent transcriptional regulators such as NFAT, MEF2, CREB, and FOXO as well as its downstream signals [<xref ref-type="bibr" rid="CR149">149</xref>]. Gene expression analysis of hiPSC-derived neurons carrying copy number variants of chromosome 15q11-q13.1 using RNA-Seq has revealed that common neuronal pathways may be disrupted in both Angelman and Dup15q syndromes [<xref ref-type="bibr" rid="CR150">150</xref>].</p>
</sec>
<sec id="Sec17">
<title>Phenotypic analyses of ASD iPSC-derived neurons: Rett, Phelan-Mcdermid, Timothy, Fragile-X, and Angelman Syndromes</title>
<p>In Rett syndrome (RTT), a neurodevelopmental ASD due primarily to mutations in the methyl-CpG binding protein 2 (MECP2) gene, hiPSC-derived neural cells show reduced soma size, dendrite spine density, differentiation, and reduced spontaneous Ca<sup>2+</sup> transient frequency in neurons and premature astroglial [<xref ref-type="bibr" rid="CR104">104</xref>–<xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR151">151</xref>, <xref ref-type="bibr" rid="CR152">152</xref>], as shown in human postmortem analyses. In addition, reduced frequency and amplitude of mEPSCs and mIPSCs [<xref ref-type="bibr" rid="CR104">104</xref>] have been observed in RTT hiPSC-derived neurons, suggesting fewer production of synapses and reduction of postsynaptic receptors [<xref ref-type="bibr" rid="CR104">104</xref>]. HiPSC-derived cellular disease models could be also used as a system for screening candidates for disease therapy since iPSC-derived neurons can recapitulate disease phenotypes in human and mouse models. Indeed, insulin-like growth factor 1 (IGF-1) was applied to hiPSC-derived RTT neurons and showed rescue of reduction in excitatory glutamatergic synaptic connections [<xref ref-type="bibr" rid="CR104">104</xref>] as in mouse models of RTT, in which reduced excitatory synaptic connections in RTT neurons could be reversed by IGF-1 application [<xref ref-type="bibr" rid="CR153">153</xref>]. IGF-1 is currently in clinical trials for RTT.</p>
<p>hiPSC-derived neurons from Phelan-Mcdermid syndrome (PMDS) patients, carrying a deletion of Shank3 protein, have significant deficits in excitatory synaptic transmission [<xref ref-type="bibr" rid="CR117">117</xref>]. These deficits were rescued by either wild-type Shank3 expression or IGF-1 treatment as in hiPSC-derived RTT neurons [<xref ref-type="bibr" rid="CR117">117</xref>], suggesting that a common signaling pathway might be involved in the pathophysiology of ASD. Therefore, hiPSC-derived neurons could be useful as a potential drug-screening platform, as mentioned above.</p>
<p>Timothy syndrome (TS) is caused by a point mutation in the voltage-gated calcium channel encoded by the <italic>CACNA1</italic> gene. TS patients iPSC-derived neurons show wider action potentials, suggesting a loss of CaV<sub>1.2</sub> channel inactivation, abnormal expression of tyrosine hydroxylase (TH), and increased production of norepinephrine and dopamine [<xref ref-type="bibr" rid="CR107">107</xref>]. Activity-dependent dendritic retraction by RhoA activation independent of Ca<sup>2+</sup> influx through CaV<sub>1.2</sub> has also been reported in TS iPSC-derived neurons [<xref ref-type="bibr" rid="CR108">108</xref>].</p>
<p>Neurons from Fragile-X syndrome patients-derived hiPSCs show reduced neurite numbers and lengths [<xref ref-type="bibr" rid="CR109">109</xref>], poor spontaneous synaptic activity, and lack reactivity to glutamate [<xref ref-type="bibr" rid="CR110">110</xref>].</p>
<p>In Angelman Syndrome (AS), which is caused by reduced expression of the maternal copy of the <italic>Ube3A</italic> gene in CNS, patient-derived iPSCs show retained genomic imprinting. In addition, electrophysiological recordings have detected AMPA receptor-mediated spontaneous activity in AS iPSC-derived mature neurons, suggesting that normal functional neurons can be generated from AS iPSCs [<xref ref-type="bibr" rid="CR111">111</xref>].</p>
<p>Recently, Muotri’s group have generated an iPSC model of a nonsyndromic ASD patient carrying a <italic>de novo</italic> balanced translocation transient receptor potential channel 6 (TRPC6) [<xref ref-type="bibr" rid="CR154">154</xref>]. TRPC6-mutant iPSC-derived neurons showed reduced neuronal arborization, fewer dendritic spines and synapses, and impaired calcium dynamics [<xref ref-type="bibr" rid="CR154">154</xref>]. They also found that MECP2 occupied the <italic>TRPC6</italic> promoter region and regulated TRPC6 expression, raising the possibility of interactions among common pathways affected in nonsyndromic and syndromic ASD.</p>
</sec>
</sec>
<sec id="Sec18" sec-type="conclusions">
<title>Conclusions</title>
<sec id="Sec19">
<title>Perspectives: limitations and future directions</title>
<sec id="Sec20">
<title>iPSC research</title>
<p>Despite numerous studies underlying the pathophysiological mechanism of ASD using iPSCs, several concerns should be addressed before iPSC research [<xref ref-type="bibr" rid="CR155">155</xref>, <xref ref-type="bibr" rid="CR156">156</xref>]. Current advances in iPSC technology have allowed us to successfully derive patient-specific iPSCs regardless of their reprogramming methods. Furthermore, a recent study showed that a modular, robotic platform for iPSC reprogramming enabled automated, high-throughput conversion of skin fibroblasts into iPSCs and their characterization/differentiation with minimal manual intervention [<xref ref-type="bibr" rid="CR157">157</xref>]. However, it still remains unknown how to obtain qualified iPSCs and improve the quality of patient-specific iPSCs under suitable and cost-effective cultivation conditions for diverse applications, including disease modeling, drug screening, and customized therapy. As mentioned above, although iPSCs are similar to ESCs in terms of pluripotent marker gene expression, self-renewal potency, differentiation potential, and their morphology, they are not identical. Recent extensive genetic analysis using high-throughput sequencing technology or generation of single-nucleotide genome-wide maps of DNA methylation has demonstrated the genomic/epigenetic differences between iPSCs and ESCs. However, the functional consequences of their differences <italic>in vitro</italic> or <italic>in vivo</italic> are largely unknown. Moreover, iPSCs and ESCs show a wide range of clonal variations in terms of proliferation and differentiation potential. Furthermore, iPSCs derived from even the same parental somatic cells have different potential in terms of expansion or differentiation [<xref ref-type="bibr" rid="CR158">158</xref>–<xref ref-type="bibr" rid="CR160">160</xref>]. Considerable somatic coding mutations occurring in hiPSC lines have also been reported by extensive exome analysis [<xref ref-type="bibr" rid="CR161">161</xref>]. The other main concern is the instability of iPSCs during passaging of clones. It has been reported that early passages of iPSCs display <italic>de novo</italic> copy number variations (CNV) during the reprogramming process [<xref ref-type="bibr" rid="CR162">162</xref>]. Thus, to obtain a more reliable outcome from iPSC research, generation of isogenic iPSCs using recent gene engineering technology or by establishment of at least 2–3 iPSC clones from the same parental somatic cells has been suggested. However, it remains unknown how these genetic/epigenetic alterations occur during reprogramming or expansion of iPSCs as well as how these alterations can be managed for iPSC generation or its application. Further, it remains unknown whether there is any reprogramming method to reduce or exclude these possible alterations as well as how to select the qualified iPSC clone from a variety of iPSC lines. To address these questions, further intensive works at the genetic/epigenetic/cellular levels are needed, and <italic>in vivo</italic> functional characterization of iPSC-derived cells needs to be carried out. Thus, the most important issue in iPSC generation is to establish more stable and standard protocols for safer and easier iPSC generation in diverse applications.</p>
<p>Although there are some differences between ESC and iPSCs, iPSCs are still the most promising choice for modeling with human cells. In mouse, iPSCs have the same potential as ESCs because a mature organism can be generated from iPSCs via blastocyst injection or tetraploid complementation [<xref ref-type="bibr" rid="CR163">163</xref>]. Although human iPSCs cannot be tested using these embryological methods owing to ethical issues and hiPSCs appear to be ‘primed’ PSCs as mouse Epi-stem cells, naïve human PSCs might be used as another human cellular model.</p>
</sec>
<sec id="Sec21">
<title>Current limitations of studies on pathophysiology using ASD iPSC-derived neurons</title>
<p>Besides iPSC line-to-line variations, limitations of studying ASD with hiPSC-derived neurons include phenotypic variations between neurons derived from the same iPSCs, which are based on differences between individual hiPSC-derived neurons from even a single patient due to heterogeneity of neuronal subtypes differentiated from each iPSC line [<xref ref-type="bibr" rid="CR164">164</xref>] even with well-defined differentiation protocols. In addition, different differentiation methods such as usage of small molecules or genes, EB formation vs. monolayer culture, concentration of small molecules and growth factors, differentiation time can also generate variations in the neuronal population. The use of cell type-specific promoters to drive expression of fluorescent markers for purification by cell sorting or identification of desired cell types would be a powerful tool to reduce variation. The surrounding environment of cells may also significantly affect the phenotypes. For example, the presence of neural progenitor cells in neuronal culture could mask disease-associated phenotypes by continuous production of newborn neurons [<xref ref-type="bibr" rid="CR112">112</xref>]. Therefore, to obtain reliable data using hiPSC-derived neurons from ASD patients, each experiment should be performed with multiple neuronal differentiation protocols from at least two or three independent hiPSC lines with the same mutation from multiple patients. In addition, forced expression of a transcription factor like <italic>Ngn2</italic> would be a good method to overcome the above described issues, in which almost ~100 % of cortical neurons at a similar maturation stage could be generated, and the neurons showed their synaptic phenotypes as early as 3 weeks after forced Ngn2 expression [<xref ref-type="bibr" rid="CR97">97</xref>].</p>
<p>As mentioned above, widespread genetic variations could exist between iPSC lines themselves derived from unrelated individuals. Therefore, genetically related family member-derived control lines could possibly be used to reduce variability of phenotypes, although it would not completely remove the possibility that even a single genetic difference could potentially affect observable phenotypes. Another possible way is to use gene correction methods since the ideal controls would be those that have the same genetic background except only the specific genetic defect found in the patient. Many well-known syndromic ASD-related genetic variants can be modeled with “isogenic” cell lines, where a patient-derived iPSC line could be gene-corrected using ZFNs, TALENs, or CRISPR-Cas9 technologies, reverting a mutant line to wild-type or vice versa [<xref ref-type="bibr" rid="CR165">165</xref>, <xref ref-type="bibr" rid="CR166">166</xref>].</p>
<p>As iPSCs are an <italic>in vitro</italic> culture system, they lack many characteristics of a developing and mature brain physiology <italic>in vivo</italic>. Therefore, it is difficult to study neuronal circuitry and organization using iPSC-derived neurons under 2D conditions, particularly when investigating phenotypes unique to specific neuronal circuits of the adult brain. One way to avoid these problems is to xenograft iPSC-derived neural progenitor cells (NPCs) into embryonic rodent brains to allow them to integrate into developing neural networks and mature <italic>in vivo</italic>. Cerebral “organoids” [<xref ref-type="bibr" rid="CR130">130</xref>] is another possible way to study disease phenotypes in a specific cell type or group of cell fates in the context of 3D model of human neurodevelopment [<xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR167">167</xref>], as reported by Mariani et al. [<xref ref-type="bibr" rid="CR132">132</xref>].</p>
<p>In summary, we can generate hiPSC-derived neurons from fibroblasts and other somatic cells of ASD patients to investigate alterations of neuronal connectivity, synaptic maturation, and functions. In addition, direct conversion of fibroblasts from ASD patients into neurons or NPC/NSCs would be used as an alternative <italic>in vitro</italic> model of ASD in the near future. However, we need to realize that hiPSC-based studies of ASD pathophysiology will not completely replace human postmortem and mouse genetic studies. Nevertheless, disease modeling with hiPSC-derived neurons combined with their comprehensive molecular and functional characterization will be a new and strong tool for understanding complex neurodevelopmental disorder, ASD.</p>
</sec>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ASD</term>
<def>
<p>Autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term>iPSC</term>
<def>
<p>induced pluripotent stem cell</p>
</def>
</def-item>
<def-item>
<term>ESCs</term>
<def>
<p>Embryonic stem cells</p>
</def>
</def-item>
<def-item>
<term>PSCs</term>
<def>
<p>Pluripotent stem cells</p>
</def>
</def-item>
<def-item>
<term>ZFN</term>
<def>
<p>Zinc finger nuclease</p>
</def>
</def-item>
<def-item>
<term>TALEN</term>
<def>
<p>Transcription activator-like effector nuclease</p>
</def>
</def-item>
<def-item>
<term>HAC</term>
<def>
<p>Human artificial chromosome</p>
</def>
</def-item>
<def-item>
<term>Wnt</term>
<def>
<p>Wingless/Int proteins</p>
</def>
</def-item>
<def-item>
<term>BMP</term>
<def>
<p>Bone morphogenic protein</p>
</def>
</def-item>
<def-item>
<term>SHH</term>
<def>
<p>Sonic hedgehog</p>
</def>
</def-item>
<def-item>
<term>FGF8</term>
<def>
<p>Fibroblast growth factor 8</p>
</def>
</def-item>
<def-item>
<term>RA</term>
<def>
<p>Retinoic acid</p>
</def>
</def-item>
<def-item>
<term>EB</term>
<def>
<p>Embryoid body</p>
</def>
</def-item>
<def-item>
<term>bFGF</term>
<def>
<p>basic fibroblast growth factor</p>
</def>
</def-item>
<def-item>
<term>TGFβ</term>
<def>
<p>Transforming growth factor β</p>
</def>
</def-item>
<def-item>
<term>
<italic>Ngn2</italic>
</term>
<def>
<p>
<italic>Neurogenin 2</italic>
</p>
</def>
</def-item>
<def-item>
<term>MRI</term>
<def>
<p>magnetic resonance imaging</p>
</def>
</def-item>
<def-item>
<term>2D</term>
<def>
<p>Two-dimensional</p>
</def>
</def-item>
<def-item>
<term>3D</term>
<def>
<p>Three-dimensional</p>
</def>
</def-item>
<def-item>
<term>RTT</term>
<def>
<p>Rett syndrome</p>
</def>
</def-item>
<def-item>
<term>
<italic>MECP2</italic>
</term>
<def>
<p>Methyl-CpG binding protein 2</p>
</def>
</def-item>
<def-item>
<term>TS</term>
<def>
<p>Timothy syndrome</p>
</def>
</def-item>
<def-item>
<term>TH</term>
<def>
<p>Tyrosine hydroxylase</p>
</def>
</def-item>
<def-item>
<term>TRPC6</term>
<def>
<p>Transient receptor potential channel 6</p>
</def>
</def-item>
<def-item>
<term>CNV</term>
<def>
<p>Copy number variation</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare that they have no competing interests.</p>
</fn>
<fn>
<p>
<bold>Authors’ contributions</bold>
</p>
<p>BK, CS, JE, KM and JA organized and wrote the manuscript. YK helped to draft tables and figures. All authors read and approved the final manuscript.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>We apologize to colleagues whose work could not be cited due to space limitations. This work was supported by National Honor Scientist Program of Korea (2012R1A3A1050385). Jin-A Lee was supported by the Basic Science Research Program through the NRF (2014R1A1A4A01003859).</p>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baird</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Simonoff</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pickles</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Loucas</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Meldrum</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)</article-title>
<source/>Lancet
          <year>2006</year>
<volume>368</volume>
<fpage>210</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(06)69041-7</pub-id>
<pub-id pub-id-type="pmid">16844490</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kogan</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Blumberg</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Schieve</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Perrin</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Ghandour</surname>
<given-names>RM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007</article-title>
<source/>Pediatrics
          <year>2009</year>
<volume>124</volume>
<fpage>1395</fpage>
<lpage>1403</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2009-1522</pub-id>
<pub-id pub-id-type="pmid">19805460</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Delaby</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Barbosa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Merikangas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Convergence of genes and cellular pathways dysregulated in autism spectrum disorders</article-title>
<source/>Am J Hum Genet
          <year>2014</year>
<volume>94</volume>
<fpage>677</fpage>
<lpage>694</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2014.03.018</pub-id>
<pub-id pub-id-type="pmid">24768552</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeremy Willsey</surname>
<given-names>A</given-names>
</name>
<name>
<surname>State</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorders: from genes to neurobiology</article-title>
<source/>Curr Opin Neurobiol
          <year>2015</year>
<volume>30C</volume>
<fpage>92</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2014.10.015</pub-id>
<pub-id pub-id-type="pmid">25464374</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devlin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>Genetic architecture in autism spectrum disorder</article-title>
<source/>Curr Opin Genet Dev
          <year>2012</year>
<volume>22</volume>
<fpage>229</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="doi">10.1016/j.gde.2012.03.002</pub-id>
<pub-id pub-id-type="pmid">22463983</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities</article-title>
<source/>Cold Spring Harb Perspect Biol
          <year>2012</year>
<volume>4</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a009886</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Cristino</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Edson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Ravine</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Towards a molecular characterization of autism spectrum disorders: an exome sequencing and systems approach</article-title>
<source/>Transl Psychiatry
          <year>2014</year>
<volume>4</volume>
<fpage>e394</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2014.38</pub-id>
<pub-id pub-id-type="pmid">24893065</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebrahimi-Fakhari</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sahin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Autism and the synapse: emerging mechanisms and mechanism-based therapies</article-title>
<source/>Curr Opin Neurol
          <year>2015</year>
<volume>28</volume>
<fpage>91</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1097/WCO.0000000000000186</pub-id>
<pub-id pub-id-type="pmid">25695134</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>From the genetic architecture to synaptic plasticity in autism spectrum disorder</article-title>
<source/>Nat Rev Neurosci
          <year>2015</year>
<volume>16</volume>
<fpage>551</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3992</pub-id>
<pub-id pub-id-type="pmid">26289574</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Won</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Gee</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Mah</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function</article-title>
<source/>Nature
          <year>2012</year>
<volume>486</volume>
<fpage>261</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1038/nature11208</pub-id>
<pub-id pub-id-type="pmid">22699620</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Riordan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Genetic aspects of autism spectrum disorders: insights from animal models</article-title>
<source/>Front Cell Neurosci
          <year>2014</year>
<volume>8</volume>
<fpage>58</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00058</pub-id>
<pub-id pub-id-type="pmid">24605088</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moy</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Nadler</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Advances in behavioral genetics: mouse models of autism</article-title>
<source/>Mol Psychiatry
          <year>2008</year>
<volume>13</volume>
<fpage>4</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4002082</pub-id>
<pub-id pub-id-type="pmid">17848915</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ey</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Leblond</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Behavioral profiles of mouse models for autism spectrum disorders</article-title>
<source/>Autism Res
          <year>2011</year>
<volume>4</volume>
<fpage>5</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1002/aur.175</pub-id>
<pub-id pub-id-type="pmid">21328568</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tordjman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Drapier</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bonnot</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Graignic</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fortes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Animal models relevant to schizophrenia and autism: validity and limitations</article-title>
<source/>Behav Genet
          <year>2007</year>
<volume>37</volume>
<fpage>61</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1007/s10519-006-9120-5</pub-id>
<pub-id pub-id-type="pmid">17160702</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tania</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Recent advances in animal model experimentation in autism research</article-title>
<source/>Acta Neuropsychiatr
          <year>2014</year>
<volume>26</volume>
<fpage>264</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1017/neu.2013.58</pub-id>
<pub-id pub-id-type="pmid">25371923</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomson</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Itskovitz-Eldor</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Waknitz</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Swiergiel</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>VS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Embryonic stem cell lines derived from human blastocysts</article-title>
<source/>Science (New York, NY)
          <year>1998</year>
<volume>282</volume>
<fpage>1145</fpage>
<lpage>1147</lpage>
<pub-id pub-id-type="doi">10.1126/science.282.5391.1145</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kirwan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Livesey</surname>
<given-names>FJ</given-names>
</name>
</person-group>
<article-title>Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses</article-title>
<source/>Nat Neurosci
          <year>2012</year>
<volume>15</volume>
<issue>477–486</issue>
<fpage>S471</fpage>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>CT</given-names>
</name>
</person-group>
<article-title>Great expectations: autism spectrum disorder and induced pluripotent stem cell technologies</article-title>
<source/>Stem Cell Rev
          <year>2014</year>
<volume>10</volume>
<fpage>145</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1007/s12015-014-9497-0</pub-id>
<pub-id pub-id-type="pmid">24488263</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Zaslavsky</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD</article-title>
<source/>Front Cell Neurosci
          <year>2014</year>
<volume>8</volume>
<fpage>109</fpage>
<pub-id pub-id-type="pmid">24782713</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prilutsky</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Smedemark-Margulies</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schlaeger</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Margulies</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Kohane</surname>
<given-names>IS</given-names>
</name>
</person-group>
<article-title>iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls</article-title>
<source/>Trends Mol Med
          <year>2014</year>
<volume>20</volume>
<fpage>91</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2013.11.004</pub-id>
<pub-id pub-id-type="pmid">24374161</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Veres</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A TALEN genome-editing system for generating human stem cell-based disease models</article-title>
<source/>Cell Stem Cell
          <year>2013</year>
<volume>12</volume>
<fpage>238</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2012.11.011</pub-id>
<pub-id pub-id-type="pmid">23246482</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lombardo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Genovese</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Beausejour</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Colleoni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery</article-title>
<source/>Nat Biotechnol
          <year>2007</year>
<volume>25</volume>
<fpage>1298</fpage>
<lpage>1306</lpage>
<pub-id pub-id-type="doi">10.1038/nbt1353</pub-id>
<pub-id pub-id-type="pmid">17965707</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kweon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chon</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A library of TAL effector nucleases spanning the human genome</article-title>
<source/>Nat Biotechnol
          <year>2013</year>
<volume>31</volume>
<fpage>251</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.2517</pub-id>
<pub-id pub-id-type="pmid">23417094</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Abalde-Atristain</surname>
<given-names>L</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brodsky</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Braunstein</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Chaudhari</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Efficient and allele-specific genome editing of disease loci in human iPSCs</article-title>
<source/>Molecular therapy : the journal of the American Society of Gene Therapy
          <year>2015</year>
<volume>23</volume>
<fpage>570</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="doi">10.1038/mt.2014.226</pub-id>
<pub-id pub-id-type="pmid">25418680</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiba</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hockemeyer</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Genome editing in human pluripotent stem cells using site-specific nucleases</article-title>
<source/>Methods in molecular biology (Clifton, NJ)
          <year>2015</year>
<volume>1239</volume>
<fpage>267</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4939-1862-1_15</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>iPS cell technologies: significance and applications to CNS regeneration and disease</article-title>
<source/>Mol Brain
          <year>2014</year>
<volume>7</volume>
<fpage>22</fpage>
<pub-id pub-id-type="doi">10.1186/1756-6606-7-22</pub-id>
<pub-id pub-id-type="pmid">24685317</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velasco</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Salazar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Giorgetti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ramos-Mejia</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Castano</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Romero-Moya</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Concise review: generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversion</article-title>
<source/>Stem cells (Dayton, Ohio)
          <year>2014</year>
<volume>32</volume>
<fpage>2811</fpage>
<lpage>2817</lpage>
<pub-id pub-id-type="doi">10.1002/stem.1782</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Direct Lineage Reprogramming: Strategies, Mechanisms, and Applications</article-title>
<source/>Cell Stem Cell
          <year>2015</year>
<volume>16</volume>
<fpage>119</fpage>
<lpage>134</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2015.01.013</pub-id>
<pub-id pub-id-type="pmid">25658369</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ambasudhan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Direct lineage reprogramming to neural cells</article-title>
<source/>Curr Opin Neurobiol
          <year>2012</year>
<volume>22</volume>
<fpage>778</fpage>
<lpage>784</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2012.05.001</pub-id>
<pub-id pub-id-type="pmid">22652035</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Nori</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Steps toward safe cell therapy using induced pluripotent stem cells</article-title>
<source/>Circ Res
          <year>2013</year>
<volume>112</volume>
<fpage>523</fpage>
<lpage>533</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.256149</pub-id>
<pub-id pub-id-type="pmid">23371901</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanabe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ohnuki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Narita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ichisaka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tomoda</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of pluripotent stem cells from adult human fibroblasts by defined factors</article-title>
<source/>Cell
          <year>2007</year>
<volume>131</volume>
<fpage>861</fpage>
<lpage>872</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2007.11.019</pub-id>
<pub-id pub-id-type="pmid">18035408</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors</article-title>
<source/>Cell
          <year>2006</year>
<volume>126</volume>
<fpage>663</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2006.07.024</pub-id>
<pub-id pub-id-type="pmid">16904174</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Kalsan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Saini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery</article-title>
<source/>Front Cell Dev Biol
          <year>2015</year>
<volume>3</volume>
<fpage>2</fpage>
<pub-id pub-id-type="doi">10.3389/fcell.2015.00002</pub-id>
<pub-id pub-id-type="pmid">25699255</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rony</surname>
<given-names>IK</given-names>
</name>
<name>
<surname>Baten</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bloomfield</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Billah</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>KD</given-names>
</name>
</person-group>
<article-title>Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming</article-title>
<source/>Cell Prolif
          <year>2015</year>
<volume>48</volume>
<fpage>140</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1111/cpr.12162</pub-id>
<pub-id pub-id-type="pmid">25643745</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells</article-title>
<source/>J Hematol Oncol
          <year>2014</year>
<volume>7</volume>
<fpage>50</fpage>
<pub-id pub-id-type="doi">10.1186/s13045-014-0050-z</pub-id>
<pub-id pub-id-type="pmid">25037625</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Integration-free methods for generating induced pluripotent stem cells</article-title>
<source/>Genomics Proteomics Bioinformatics
          <year>2013</year>
<volume>11</volume>
<fpage>284</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="doi">10.1016/j.gpb.2013.09.008</pub-id>
<pub-id pub-id-type="pmid">24121200</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petit</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kesner</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Karry</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Robicsek</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Aberdam</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>FJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders</article-title>
<source/>Stem Cell Res
          <year>2012</year>
<volume>8</volume>
<fpage>134</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1016/j.scr.2011.09.003</pub-id>
<pub-id pub-id-type="pmid">22099027</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raab</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Klingenstein</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liebau</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Linta</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>A Comparative View on Human Somatic Cell Sources for iPSC Generation</article-title>
<source/>Stem Cells Int
          <year>2014</year>
<volume>2014</volume>
<fpage>768391</fpage>
<pub-id pub-id-type="doi">10.1155/2014/768391</pub-id>
<pub-id pub-id-type="pmid">25431601</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Goode</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heemsbergen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mawhood</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autism diagnostic observation schedule: a standardized observation of communicative and social behavior</article-title>
<source/>J Autism Dev Disord
          <year>1989</year>
<volume>19</volume>
<fpage>185</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1007/BF02211841</pub-id>
<pub-id pub-id-type="pmid">2745388</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Le Couteur</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders</article-title>
<source/>J Autism Dev Disord
          <year>1994</year>
<volume>24</volume>
<fpage>659</fpage>
<lpage>685</lpage>
<pub-id pub-id-type="doi">10.1007/BF02172145</pub-id>
<pub-id pub-id-type="pmid">7814313</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Guy</surname>
<given-names>W</given-names>
</name>
</person-group>
<source/>ECDEU Assessment Manual for Psychopharmacology
          <year>1976</year>
<publisher-loc>Rockville, Md</publisher-loc>
<publisher-name>US Department of Health, Education, and Welfare</publisher-name>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schopler</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Reichler</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>DeVellis</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS)</article-title>
<source/>J Autism Dev Disord
          <year>1980</year>
<volume>10</volume>
<fpage>91</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1007/BF02408436</pub-id>
<pub-id pub-id-type="pmid">6927682</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayes</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Calhoun</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Yurich</surname>
<given-names>KKL</given-names>
</name>
<name>
<surname>Cothren</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Use of the Childhood Autism Rating Scale (CARS) for Children With High Functioning Autism or Asperger Syndrome</article-title>
<source/>Focus on Autism and Other Developmental Disabilities
          <year>2012</year>
<volume>27</volume>
<fpage>31</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1177/1088357611406902</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krug</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Arick</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Almond</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior</article-title>
<source/>J Child Psychol Psychiatry
          <year>1980</year>
<volume>21</volume>
<fpage>221</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-7610.1980.tb01797.x</pub-id>
<pub-id pub-id-type="pmid">7430288</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volkmar</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Cicchetti</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Dykens</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sparrow</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Leckman</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>An evaluation of the Autism Behavior Checklist</article-title>
<source/>J Autism Dev Disord
          <year>1988</year>
<volume>18</volume>
<fpage>81</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1007/BF02211820</pub-id>
<pub-id pub-id-type="pmid">3372461</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Constantino</surname>
<given-names>J</given-names>
</name>
</person-group>
<source/>The social responsiveness scale
          <year>2002</year>
<publisher-loc>Los Angeles</publisher-loc>
<publisher-name>Western Psychological Services</publisher-name>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aldridge</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Schmidhofer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Investigating the clinical usefulness of the Social Responsiveness Scale (SRS) in a tertiary level, autism spectrum disorder specific assessment clinic</article-title>
<source/>J Autism Dev Disord
          <year>2012</year>
<volume>42</volume>
<fpage>294</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-011-1242-9</pub-id>
<pub-id pub-id-type="pmid">21516433</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Wechsler</surname>
<given-names>D</given-names>
</name>
</person-group>
<source/>The Measurement of Adult Intelligence
          <year>1939</year>
<publisher-loc>Baltimore</publisher-loc>
<publisher-name>Williams &amp; Wilkins</publisher-name>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dowey</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression</article-title>
<source/>Nat Protoc
          <year>2012</year>
<volume>7</volume>
<fpage>2013</fpage>
<lpage>2021</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2012.121</pub-id>
<pub-id pub-id-type="pmid">23080273</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Quintana-Bustamante</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Segovia</surname>
<given-names>JC</given-names>
</name>
</person-group>
<source/>Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors
          <year>2014</year>
<publisher-loc>Clifton, N.J</publisher-loc>
<publisher-name>Methods in molecular biology</publisher-name>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vodyanik</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Smuga-Otto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Antosiewicz-Bourget</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Frane</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induced pluripotent stem cell lines derived from human somatic cells</article-title>
<source/>Science (New York, NY)
          <year>2007</year>
<volume>318</volume>
<fpage>1917</fpage>
<lpage>1920</lpage>
<pub-id pub-id-type="doi">10.1126/science.1151526</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maherali</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hochedlinger</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Guidelines and techniques for the generation of induced pluripotent stem cells</article-title>
<source/>Cell Stem Cell
          <year>2008</year>
<volume>3</volume>
<fpage>595</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2008.11.008</pub-id>
<pub-id pub-id-type="pmid">19041776</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nori</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Itakura</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition</article-title>
<source/>Stem Cell Rep
          <year>2015</year>
<volume>4</volume>
<fpage>360</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2015.01.006</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>HG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neural stem cells differentiated from iPS cells spontaneously regain pluripotency</article-title>
<source/>Stem cells (Dayton, Ohio)
          <year>2014</year>
<volume>32</volume>
<fpage>2596</fpage>
<lpage>2604</lpage>
<pub-id pub-id-type="doi">10.1002/stem.1757</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fusaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ban</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saeki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome</article-title>
<source/>Proc Jpn Acad Ser B Phys Biol Sci
          <year>2009</year>
<volume>85</volume>
<fpage>348</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.2183/pjab.85.348</pub-id>
<pub-id pub-id-type="pmid">19838014</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stadtfeld</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nagaya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Utikal</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weir</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hochedlinger</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Induced pluripotent stem cells generated without viral integration</article-title>
<source/>Science (New York, NY)
          <year>2008</year>
<volume>322</volume>
<fpage>945</fpage>
<lpage>949</lpage>
<pub-id pub-id-type="doi">10.1126/science.1162494</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okita</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hyenjong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ichisaka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Generation of mouse induced pluripotent stem cells without viral vectors</article-title>
<source/>Science (New York, NY)
          <year>2008</year>
<volume>322</volume>
<fpage>949</fpage>
<lpage>953</lpage>
<pub-id pub-id-type="doi">10.1126/science.1164270</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Somers</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jean</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Omari</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette</article-title>
<source/>Stem cells (Dayton, Ohio)
          <year>2010</year>
<volume>28</volume>
<fpage>1728</fpage>
<lpage>1740</lpage>
<pub-id pub-id-type="doi">10.1002/stem.495</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woltjen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Michael</surname>
<given-names>IP</given-names>
</name>
<name>
<surname>Mohseni</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mileikovsky</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hamalainen</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells</article-title>
<source/>Nature
          <year>2009</year>
<volume>458</volume>
<fpage>766</fpage>
<lpage>770</lpage>
<pub-id pub-id-type="doi">10.1038/nature07863</pub-id>
<pub-id pub-id-type="pmid">19252478</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>BS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins</article-title>
<source/>Cell Stem Cell
          <year>2009</year>
<volume>4</volume>
<fpage>472</fpage>
<lpage>476</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2009.05.005</pub-id>
<pub-id pub-id-type="pmid">19481515</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warren</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Manos</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Ahfeldt</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Loh</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA</article-title>
<source/>Cell Stem Cell
          <year>2010</year>
<volume>7</volume>
<fpage>618</fpage>
<lpage>630</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2010.08.012</pub-id>
<pub-id pub-id-type="pmid">20888316</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Dang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rana</surname>
<given-names>TM</given-names>
</name>
</person-group>
<source/>Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA
          <year>2015</year>
<publisher-loc>Clifton, N.J</publisher-loc>
<publisher-name>Methods in molecular biology</publisher-name>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshioka</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gros</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Deacon</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Maron</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Efficient generation of human iPSCs by a synthetic self-replicative RNA</article-title>
<source/>Cell Stem Cell
          <year>2013</year>
<volume>13</volume>
<fpage>246</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2013.06.001</pub-id>
<pub-id pub-id-type="pmid">23910086</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woodard</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>piggyBac-ing models and new therapeutic strategies</article-title>
<source/>Trends Biotechnol
          <year>2015</year>
<volume>33</volume>
<fpage>525</fpage>
<lpage>533</lpage>
<pub-id pub-id-type="doi">10.1016/j.tibtech.2015.06.009</pub-id>
<pub-id pub-id-type="pmid">26211958</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Reprogramming with Small Molecules instead of Exogenous Transcription Factors</article-title>
<source/>Stem Cells Int
          <year>2015</year>
<volume>2015</volume>
<fpage>794632</fpage>
<pub-id pub-id-type="doi">10.1155/2015/794632</pub-id>
<pub-id pub-id-type="pmid">25922608</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ban</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nishishita</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fusaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tabata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Saeki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shikamura</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2011</year>
<volume>108</volume>
<fpage>14234</fpage>
<lpage>14239</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1103509108</pub-id>
<pub-id pub-id-type="pmid">21821793</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujie</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fusaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Katayama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hamasaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Soejima</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Soga</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<fpage>e113052</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0113052</pub-id>
<pub-id pub-id-type="pmid">25479600</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Freed</surname>
<given-names>CR</given-names>
</name>
</person-group>
<article-title>Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells</article-title>
<source/>Stem cells (Dayton, Ohio)
          <year>2009</year>
<volume>27</volume>
<fpage>2667</fpage>
<lpage>2674</lpage>
<pub-id pub-id-type="doi">10.1002/stem.201</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okita</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Matsumura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Morizane</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A more efficient method to generate integration-free human iPS cells</article-title>
<source/>Nat Methods
          <year>2011</year>
<volume>8</volume>
<fpage>409</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.1591</pub-id>
<pub-id pub-id-type="pmid">21460823</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaji</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Norrby</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Paca</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mileikovsky</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mohseni</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Woltjen</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Virus-free induction of pluripotency and subsequent excision of reprogramming factors</article-title>
<source/>Nature
          <year>2009</year>
<volume>458</volume>
<fpage>771</fpage>
<lpage>775</lpage>
<pub-id pub-id-type="doi">10.1038/nature07864</pub-id>
<pub-id pub-id-type="pmid">19252477</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Pawlik</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Polycistronic lentiviral vector for “hit and run” reprogramming of adult skin fibroblasts to induced pluripotent stem cells</article-title>
<source/>Stem cells (Dayton, Ohio)
          <year>2009</year>
<volume>27</volume>
<fpage>1042</fpage>
<lpage>1049</lpage>
<pub-id pub-id-type="doi">10.1002/stem.39</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tahimic</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Katoh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kurimasa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oshimura</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Human artificial chromosome vectors meet stem cells: new prospects for gene delivery</article-title>
<source/>Stem Cell Rev
          <year>2006</year>
<volume>2</volume>
<fpage>43</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">17142886</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A nonviral minicircle vector for deriving human iPS cells</article-title>
<source/>Nat Methods
          <year>2010</year>
<volume>7</volume>
<fpage>197</fpage>
<lpage>199</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.1426</pub-id>
<pub-id pub-id-type="pmid">20139967</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiratsuka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Uno</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kurosaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Imaoka</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kazuki</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integration-free iPS cells engineered using human artificial chromosome vectors</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<fpage>e25961</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0025961</pub-id>
<pub-id pub-id-type="pmid">21998730</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narsinh</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Longaker</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors</article-title>
<source/>Nat Protoc
          <year>2011</year>
<volume>6</volume>
<fpage>78</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2010.173</pub-id>
<pub-id pub-id-type="pmid">21212777</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malik</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>A review of the methods for human iPSC derivation</article-title>
<source/>Methods in molecular biology (Clifton, NJ)
          <year>2013</year>
<volume>997</volume>
<fpage>23</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-62703-348-0_3</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huangfu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Maehr</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Eijkelenboom</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Snitow</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>AE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds</article-title>
<source/>Nat Biotechnol
          <year>2008</year>
<volume>26</volume>
<fpage>795</fpage>
<lpage>797</lpage>
<pub-id pub-id-type="doi">10.1038/nbt1418</pub-id>
<pub-id pub-id-type="pmid">18568017</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huangfu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Osafune</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Maehr</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Eijkelenboom</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2</article-title>
<source/>Nat Biotechnol
          <year>2008</year>
<volume>26</volume>
<fpage>1269</fpage>
<lpage>1275</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.1502</pub-id>
<pub-id pub-id-type="pmid">18849973</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Abujarour</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Young Joo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2</article-title>
<source/>Stem cells (Dayton, Ohio)
          <year>2009</year>
<volume>27</volume>
<fpage>2992</fpage>
<lpage>3000</lpage>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds</article-title>
<source/>Science (New York, NY)
          <year>2013</year>
<volume>341</volume>
<fpage>651</fpage>
<lpage>654</lpage>
<pub-id pub-id-type="doi">10.1126/science.1239278</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schlaeger</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Daheron</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Brickler</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Entwisle</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cianci</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A comparison of non-integrating reprogramming methods</article-title>
<source/>Nat Biotechnol
          <year>2015</year>
<volume>33</volume>
<fpage>58</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.3070</pub-id>
<pub-id pub-id-type="pmid">25437882</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaspard</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Vanderhaeghen</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Mechanisms of neural specification from embryonic stem cells</article-title>
<source/>Curr Opin Neurobiol
          <year>2010</year>
<volume>20</volume>
<fpage>37</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2009.12.001</pub-id>
<pub-id pub-id-type="pmid">20080043</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perrier</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Tabar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Barberi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rubio</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Bruses</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Topf</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Derivation of midbrain dopamine neurons from human embryonic stem cells</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2004</year>
<volume>101</volume>
<fpage>12543</fpage>
<lpage>12548</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0404700101</pub-id>
<pub-id pub-id-type="pmid">15310843</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Lumelsky</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Studer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Auerbach</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>McKay</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells</article-title>
<source/>Nat Biotechnol
          <year>2000</year>
<volume>18</volume>
<fpage>675</fpage>
<lpage>679</lpage>
<pub-id pub-id-type="doi">10.1038/76536</pub-id>
<pub-id pub-id-type="pmid">10835609</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wichterle</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lieberam</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Jessell</surname>
<given-names>TM</given-names>
</name>
</person-group>
<article-title>Directed differentiation of embryonic stem cells into motor neurons</article-title>
<source/>Cell
          <year>2002</year>
<volume>110</volume>
<fpage>385</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(02)00835-8</pub-id>
<pub-id pub-id-type="pmid">12176325</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>ZW</given-names>
</name>
<name>
<surname>Zarnowska</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Pankratz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>LO</given-names>
</name>
<name>
<surname>Pearce</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Specification of motoneurons from human embryonic stem cells</article-title>
<source/>Nat Biotechnol
          <year>2005</year>
<volume>23</volume>
<fpage>215</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1038/nbt1063</pub-id>
<pub-id pub-id-type="pmid">15685164</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Wernig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Brustle</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>In vitro differentiation of transplantable neural precursors from human embryonic stem cells</article-title>
<source/>Nat Biotechnol
          <year>2001</year>
<volume>19</volume>
<fpage>1129</fpage>
<lpage>1133</lpage>
<pub-id pub-id-type="doi">10.1038/nbt1201-1129</pub-id>
<pub-id pub-id-type="pmid">11731781</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okabe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Forsberg-Nilsson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Spiro</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McKay</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro</article-title>
<source/>Mech Dev
          <year>1996</year>
<volume>59</volume>
<fpage>89</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1016/0925-4773(96)00572-2</pub-id>
<pub-id pub-id-type="pmid">8892235</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imaizumi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Akamatsu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Koike</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kuzumaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hayakawa</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue</article-title>
<source/>Mol Brain
          <year>2012</year>
<volume>5</volume>
<fpage>35</fpage>
<pub-id pub-id-type="doi">10.1186/1756-6606-5-35</pub-id>
<pub-id pub-id-type="pmid">23039195</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Numasawa-Kuroiwa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kishi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Akamatsu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Shoji</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes</article-title>
<source/>Stem Cell Rep
          <year>2014</year>
<volume>2</volume>
<fpage>648</fpage>
<lpage>661</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2014.03.007</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barberi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Klivenyi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Calingasan</surname>
<given-names>NY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kawamata</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Loonam</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice</article-title>
<source/>Nat Biotechnol
          <year>2003</year>
<volume>21</volume>
<fpage>1200</fpage>
<lpage>1207</lpage>
<pub-id pub-id-type="doi">10.1038/nbt870</pub-id>
<pub-id pub-id-type="pmid">14502203</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawasaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mizuseki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nishikawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kuwana</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity</article-title>
<source/>Neuron
          <year>2000</year>
<volume>28</volume>
<fpage>31</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)00083-0</pub-id>
<pub-id pub-id-type="pmid">11086981</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vierbuchen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ostermeier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>ZP</given-names>
</name>
<name>
<surname>Kokubu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sudhof</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Wernig</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Direct conversion of fibroblasts to functional neurons by defined factors</article-title>
<source/>Nature
          <year>2010</year>
<volume>463</volume>
<fpage>1035</fpage>
<lpage>1041</lpage>
<pub-id pub-id-type="doi">10.1038/nature08797</pub-id>
<pub-id pub-id-type="pmid">20107439</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pang</surname>
<given-names>ZP</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Vierbuchen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ostermeier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fuentes</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>TQ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of human neuronal cells by defined transcription factors</article-title>
<source/>Nature
          <year>2011</year>
<volume>476</volume>
<fpage>220</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="pmid">21617644</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ambasudhan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Talantova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lipton</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions</article-title>
<source/>Cell Stem Cell
          <year>2011</year>
<volume>9</volume>
<fpage>113</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2011.07.002</pub-id>
<pub-id pub-id-type="pmid">21802386</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoo</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>AX</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shcheglovitov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Portmann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-mediated conversion of human fibroblasts to neurons</article-title>
<source/>Nature
          <year>2011</year>
<volume>476</volume>
<fpage>228</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1038/nature10323</pub-id>
<pub-id pub-id-type="pmid">21753754</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pak</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ahlenius</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chanda</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rapid single-step induction of functional neurons from human pluripotent stem cells</article-title>
<source/>Neuron
          <year>2013</year>
<volume>78</volume>
<fpage>785</fpage>
<lpage>798</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.05.029</pub-id>
<pub-id pub-id-type="pmid">23764284</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babos</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ichida</surname>
<given-names>JK</given-names>
</name>
</person-group>
<article-title>Small Molecules Take a Big Step by Converting Fibroblasts into Neurons</article-title>
<source/>Cell Stem Cell
          <year>2015</year>
<volume>17</volume>
<fpage>127</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2015.07.018</pub-id>
<pub-id pub-id-type="pmid">26253195</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons</article-title>
<source/>Cell Stem Cell
          <year>2015</year>
<volume>17</volume>
<fpage>195</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2015.06.003</pub-id>
<pub-id pub-id-type="pmid">26253201</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Direct Conversion of Normal and Alzheimer’s Disease Human Fibroblasts into Neuronal Cells by Small Molecules</article-title>
<source/>Cell Stem Cell
          <year>2015</year>
<volume>17</volume>
<fpage>204</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2015.07.006</pub-id>
<pub-id pub-id-type="pmid">26253202</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>HN</given-names>
</name>
<name>
<surname>Byers</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cord</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Shcheglovitov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Byrne</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gujar</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress</article-title>
<source/>Cell Stem Cell
          <year>2011</year>
<volume>8</volume>
<fpage>267</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2011.01.013</pub-id>
<pub-id pub-id-type="pmid">21362567</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seibler</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Graziotto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Simunovic</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Krainc</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells</article-title>
<source/>The Journal of neuroscience : the official journal of the Society for Neuroscience
          <year>2011</year>
<volume>31</volume>
<fpage>5970</fpage>
<lpage>5976</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4441-10.2011</pub-id>
<pub-id pub-id-type="pmid">21508222</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bain</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kitchens</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huettner</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Gottlieb</surname>
<given-names>DI</given-names>
</name>
</person-group>
<article-title>Embryonic stem cells express neuronal properties in vitro</article-title>
<source/>Dev Biol
          <year>1995</year>
<volume>168</volume>
<fpage>342</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1006/dbio.1995.1085</pub-id>
<pub-id pub-id-type="pmid">7729574</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchetto</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Carromeu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Acab</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells</article-title>
<source/>Cell
          <year>2010</year>
<volume>143</volume>
<fpage>527</fpage>
<lpage>539</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2010.10.016</pub-id>
<pub-id pub-id-type="pmid">21074045</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheung</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Grafodatskaya</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pasceri</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Weksberg</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hotta</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation</article-title>
<source/>Hum Mol Genet
          <year>2011</year>
<volume>20</volume>
<fpage>2103</fpage>
<lpage>2115</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddr093</pub-id>
<pub-id pub-id-type="pmid">21372149</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Hysolli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>IH</given-names>
</name>
</person-group>
<article-title>Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2011</year>
<volume>108</volume>
<fpage>14169</fpage>
<lpage>14174</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1018979108</pub-id>
<pub-id pub-id-type="pmid">21807996</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pasca</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Portmann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Yazawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shcheglovitov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pasca</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome</article-title>
<source/>Nat Med
          <year>2011</year>
<volume>17</volume>
<fpage>1657</fpage>
<lpage>1662</lpage>
<pub-id pub-id-type="doi">10.1038/nm.2576</pub-id>
<pub-id pub-id-type="pmid">22120178</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krey</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Pasca</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Shcheglovitov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yazawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schwemberger</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rasmusson</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons</article-title>
<source/>Nat Neurosci
          <year>2013</year>
<volume>16</volume>
<fpage>201</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3307</pub-id>
<pub-id pub-id-type="pmid">23313911</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheridan</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Theriault</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Madison</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Daheron</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<fpage>e26203</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0026203</pub-id>
<pub-id pub-id-type="pmid">22022567</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Telias</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ben-Yosef</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Neural differentiation of Fragile X human Embryonic Stem Cells reveals abnormal patterns of development despite successful neurogenesis</article-title>
<source/>Dev Biol
          <year>2013</year>
<volume>374</volume>
<fpage>32</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2012.11.031</pub-id>
<pub-id pub-id-type="pmid">23219959</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chamberlain</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Bourgois-Rocha</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lemtiri-Chlieh</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>ES</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<fpage>17668</fpage>
<lpage>17673</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1004487107</pub-id>
<pub-id pub-id-type="pmid">20876107</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandoe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Eggan</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Opportunities and challenges of pluripotent stem cell neurodegenerative disease models</article-title>
<source/>Nat Neurosci
          <year>2013</year>
<volume>16</volume>
<fpage>780</fpage>
<lpage>789</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3425</pub-id>
<pub-id pub-id-type="pmid">23799470</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Eggan</surname>
<given-names>KC</given-names>
</name>
</person-group>
<article-title>Constructing and deconstructing stem cell models of neurological disease</article-title>
<source/>Neuron
          <year>2011</year>
<volume>70</volume>
<fpage>626</fpage>
<lpage>644</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.003</pub-id>
<pub-id pub-id-type="pmid">21609821</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Fasano</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Papapetrou</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Tomishima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sadelain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Studer</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling</article-title>
<source/>Nat Biotechnol
          <year>2009</year>
<volume>27</volume>
<fpage>275</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.1529</pub-id>
<pub-id pub-id-type="pmid">19252484</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Chambers</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Mica</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Studer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tomishima</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<source/>Dual-SMAD Inhibition/WNT Activation-Based Methods to Induce Neural Crest and Derivatives from Human Pluripotent Stem Cells
          <year>2013</year>
<publisher-loc>Clifton, N.J</publisher-loc>
<publisher-name>Methods in molecular biology</publisher-name>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pera</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Houssami</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Reubinoff</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Trounson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>EG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin</article-title>
<source/>J Cell Sci
          <year>2004</year>
<volume>117</volume>
<fpage>1269</fpage>
<lpage>1280</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.00970</pub-id>
<pub-id pub-id-type="pmid">14996946</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shcheglovitov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shcheglovitova</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Yazawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Portmann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sebastiano</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients</article-title>
<source/>Nature
          <year>2013</year>
<volume>503</volume>
<fpage>267</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="pmid">24132240</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chanda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Davila</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pak</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mall</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>QY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Generation of induced neuronal cells by the single reprogramming factor ASCL1</article-title>
<source/>Stem Cell Rep
          <year>2014</year>
<volume>3</volume>
<fpage>282</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2014.05.020</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chanda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Marro</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wernig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sudhof</surname>
<given-names>TC</given-names>
</name>
</person-group>
<article-title>Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutation</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2013</year>
<volume>110</volume>
<fpage>16622</fpage>
<lpage>16627</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1316240110</pub-id>
<pub-id pub-id-type="pmid">24046374</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoo</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>AX</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shcheglovitov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Portmann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-mediated conversion of human fibroblasts to neurons</article-title>
<source/>Nature
          <year>2011</year>
<volume>476</volume>
<fpage>228</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1038/nature10323</pub-id>
<pub-id pub-id-type="pmid">21753754</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ladewig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kesavan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Doerr</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Poppe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Glaue</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Small molecules enable highly efficient neuronal conversion of human fibroblasts</article-title>
<source/>Nat Methods
          <year>2012</year>
<volume>9</volume>
<fpage>575</fpage>
<lpage>578</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.1972</pub-id>
<pub-id pub-id-type="pmid">22484851</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Efe</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Talantova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Direct reprogramming of mouse fibroblasts to neural progenitors</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2011</year>
<volume>108</volume>
<fpage>7838</fpage>
<lpage>7843</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1103113108</pub-id>
<pub-id pub-id-type="pmid">21521790</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Worsdorfer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lakes</surname>
<given-names>YB</given-names>
</name>
<name>
<surname>Gorris</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Herms</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Opitz</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Direct conversion of fibroblasts into stably expandable neural stem cells</article-title>
<source/>Cell Stem Cell
          <year>2012</year>
<volume>10</volume>
<fpage>473</fpage>
<lpage>479</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2012.03.003</pub-id>
<pub-id pub-id-type="pmid">22445518</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Tapia</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hermann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hemmer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hoing</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arauzo-Bravo</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Direct reprogramming of fibroblasts into neural stem cells by defined factors</article-title>
<source/>Cell Stem Cell
          <year>2012</year>
<volume>10</volume>
<fpage>465</fpage>
<lpage>472</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2012.02.021</pub-id>
<pub-id pub-id-type="pmid">22445517</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ring</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Balestra</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Javier</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Andrews-Zwilling</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor</article-title>
<source/>Cell Stem Cell
          <year>2012</year>
<volume>11</volume>
<fpage>100</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2012.05.018</pub-id>
<pub-id pub-id-type="pmid">22683203</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Flasskamp</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hermann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Arauzo-Bravo</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Direct conversion of mouse fibroblasts into induced neural stem cells</article-title>
<source/>Nat Protoc
          <year>2014</year>
<volume>9</volume>
<fpage>871</fpage>
<lpage>881</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2014.056</pub-id>
<pub-id pub-id-type="pmid">24651499</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Just</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Cherkassky</surname>
<given-names>VL</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Kana</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Minshew</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>Functional and anatomical cortical underconnectivity in autism: evidence from an FMRI study of an executive function task and corpus callosum morphometry</article-title>
<source/>Cerebral cortex (New York, NY : 1991)
          <year>2007</year>
<volume>17</volume>
<fpage>951</fpage>
<lpage>961</lpage>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brennand</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Gage</surname>
<given-names>FH</given-names>
</name>
</person-group>
<article-title>Modeling psychiatric disorders through reprogramming</article-title>
<source/>Dis Model Mech
          <year>2012</year>
<volume>5</volume>
<fpage>26</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1242/dmm.008268</pub-id>
<pub-id pub-id-type="pmid">21954066</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amaral</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Nordahl</surname>
<given-names>CW</given-names>
</name>
</person-group>
<article-title>Neuroanatomy of autism</article-title>
<source/>Trends Neurosci
          <year>2008</year>
<volume>31</volume>
<fpage>137</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2007.12.005</pub-id>
<pub-id pub-id-type="pmid">18258309</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lancaster</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Wenzel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bicknell</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Hurles</surname>
<given-names>ME</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cerebral organoids model human brain development and microcephaly</article-title>
<source/>Nature
          <year>2013</year>
<volume>501</volume>
<fpage>373</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="doi">10.1038/nature12517</pub-id>
<pub-id pub-id-type="pmid">23995685</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lancaster</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Knoblich</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Generation of cerebral organoids from human pluripotent stem cells</article-title>
<source/>Nat Protoc
          <year>2014</year>
<volume>9</volume>
<fpage>2329</fpage>
<lpage>2340</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2014.158</pub-id>
<pub-id pub-id-type="pmid">25188634</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mariani</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Abyzov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Provini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tomasini</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders</article-title>
<source/>Cell
          <year>2015</year>
<volume>162</volume>
<fpage>375</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.06.034</pub-id>
<pub-id pub-id-type="pmid">26186191</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farra</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Pasceri</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Eubanks</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Salter</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations</article-title>
<source/>Mol Psychiatry
          <year>2012</year>
<volume>17</volume>
<fpage>1261</fpage>
<lpage>1271</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2011.180</pub-id>
<pub-id pub-id-type="pmid">22230884</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urbach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bar-Nur</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Daley</surname>
<given-names>GQ</given-names>
</name>
<name>
<surname>Benvenisty</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells</article-title>
<source/>Cell Stem Cell
          <year>2010</year>
<volume>6</volume>
<fpage>407</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2010.04.005</pub-id>
<pub-id pub-id-type="pmid">20452313</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mullen</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Buck</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>NeuN, a neuronal specific nuclear protein in vertebrates</article-title>
<source/>Development
          <year>1992</year>
<volume>116</volume>
<fpage>201</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="pmid">1483388</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonfanti</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Theodosis</surname>
<given-names>DT</given-names>
</name>
</person-group>
<article-title>Expression of polysialylated neural cell adhesion molecule by proliferating cells in the subependymal layer of the adult rat, in its rostral extension and in the olfactory bulb</article-title>
<source/>Neuroscience
          <year>1994</year>
<volume>62</volume>
<fpage>291</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4522(94)90333-6</pub-id>
<pub-id pub-id-type="pmid">7816207</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>von Bohlen Und Halbach</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Immunohistological markers for staging neurogenesis in adult hippocampus</article-title>
<source/>Cell Tissue Res
          <year>2007</year>
<volume>329</volume>
<fpage>409</fpage>
<lpage>420</lpage>
<pub-id pub-id-type="doi">10.1007/s00441-007-0432-4</pub-id>
<pub-id pub-id-type="pmid">17541643</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takamori</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rhee</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Rosenmund</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jahn</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons</article-title>
<source/>Nature
          <year>2000</year>
<volume>407</volume>
<fpage>189</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1038/35025070</pub-id>
<pub-id pub-id-type="pmid">11001057</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaufman</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Houser</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Tobin</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions</article-title>
<source/>J Neurochem
          <year>1991</year>
<volume>56</volume>
<fpage>720</fpage>
<lpage>723</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.1991.tb08211.x</pub-id>
<pub-id pub-id-type="pmid">1988566</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pickel</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Joh</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Field</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Cellular localization of tyrosine hydroxylase by immunohistochemistry</article-title>
<source/>The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
          <year>1975</year>
<volume>23</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1177/23.1.234988</pub-id>
<pub-id pub-id-type="pmid">234988</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frantz</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Weimann</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>McConnell</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>Otx1 and Otx2 define layers and regions in developing cerebral cortex and cerebellum</article-title>
<source/>The Journal of neuroscience : the official journal of the Society for Neuroscience
          <year>1994</year>
<volume>14</volume>
<fpage>5725</fpage>
<lpage>5740</lpage>
<pub-id pub-id-type="pmid">7931541</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weimann</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>YA</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Devine</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Brulet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McConnell</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>Cortical neurons require Otx1 for the refinement of exuberant axonal projections to subcortical targets</article-title>
<source/>Neuron
          <year>1999</year>
<volume>24</volume>
<fpage>819</fpage>
<lpage>831</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)81030-2</pub-id>
<pub-id pub-id-type="pmid">10624946</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arlotta</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Molyneaux</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kominami</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Macklis</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo</article-title>
<source/>Neuron
          <year>2005</year>
<volume>45</volume>
<fpage>207</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2004.12.036</pub-id>
<pub-id pub-id-type="pmid">15664173</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bulfone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Smiga</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Shimamura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Puelles</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>T-brain-1: a homolog of Brachyury whose expression defines molecularly distinct domains within the cerebral cortex</article-title>
<source/>Neuron
          <year>1995</year>
<volume>15</volume>
<fpage>63</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1016/0896-6273(95)90065-9</pub-id>
<pub-id pub-id-type="pmid">7619531</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedogni</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hodge</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Elsen</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Daza</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Beyer</surname>
<given-names>RP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<fpage>13129</fpage>
<lpage>13134</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1002285107</pub-id>
<pub-id pub-id-type="pmid">20615956</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nieto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Monuki</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Imitola</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Haubst</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Khoury</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex</article-title>
<source/>J Comp Neurol
          <year>2004</year>
<volume>479</volume>
<fpage>168</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1002/cne.20322</pub-id>
<pub-id pub-id-type="pmid">15452856</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alcamo</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Chirivella</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dautzenberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dobreva</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Farinas</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Grosschedl</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Satb2 regulates callosal projection neuron identity in the developing cerebral cortex</article-title>
<source/>Neuron
          <year>2008</year>
<volume>57</volume>
<fpage>364</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.12.012</pub-id>
<pub-id pub-id-type="pmid">18255030</pub-id>
</element-citation>
</ref>
<ref id="CR148">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Britanova</surname>
<given-names>O</given-names>
</name>
<name>
<surname>de Juan Romero</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Schwark</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gyorgy</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex</article-title>
<source/>Neuron
          <year>2008</year>
<volume>57</volume>
<fpage>378</fpage>
<lpage>392</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.12.028</pub-id>
<pub-id pub-id-type="pmid">18255031</pub-id>
</element-citation>
</ref>
<ref id="CR149">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pasca</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chandran</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alteration in basal and depolarization induced transcriptional network in iPSC derived neurons from Timothy syndrome</article-title>
<source/>Genome Med
          <year>2014</year>
<volume>6</volume>
<fpage>75</fpage>
<pub-id pub-id-type="doi">10.1186/s13073-014-0075-5</pub-id>
<pub-id pub-id-type="pmid">25360157</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Germain</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Plocik</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Glatt-Deeley</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1</article-title>
<source/>Mol Autism
          <year>2014</year>
<volume>5</volume>
<fpage>44</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-5-44</pub-id>
<pub-id pub-id-type="pmid">25694803</pub-id>
</element-citation>
</ref>
<ref id="CR151">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ananiev</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<fpage>e25255</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0025255</pub-id>
<pub-id pub-id-type="pmid">21966470</pub-id>
</element-citation>
</ref>
<ref id="CR152">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andoh-Noda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Akamatsu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sanosaka</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage</article-title>
<source/>Mol Brain
          <year>2015</year>
<volume>8</volume>
<fpage>31</fpage>
<pub-id pub-id-type="doi">10.1186/s13041-015-0121-2</pub-id>
<pub-id pub-id-type="pmid">26012557</pub-id>
</element-citation>
</ref>
<ref id="CR153">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tropea</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Giacometti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Beard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McCurry</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>DD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2009</year>
<volume>106</volume>
<fpage>2029</fpage>
<lpage>2034</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0812394106</pub-id>
<pub-id pub-id-type="pmid">19208815</pub-id>
</element-citation>
</ref>
<ref id="CR154">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griesi-Oliveira</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Acab</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Sunaga</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Chailangkarn</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nicol</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>20</volume>
<fpage>361</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="pmid">24686136</pub-id>
</element-citation>
</ref>
<ref id="CR155">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panopoulos</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Izpisua Belmonte</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>iPSCs: induced back to controversy</article-title>
<source/>Cell Stem Cell
          <year>2011</year>
<volume>8</volume>
<fpage>347</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2011.03.003</pub-id>
<pub-id pub-id-type="pmid">21474093</pub-id>
</element-citation>
</ref>
<ref id="CR156">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Loh</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality</article-title>
<source/>Protein Cell
          <year>2012</year>
<volume>3</volume>
<fpage>834</fpage>
<lpage>845</lpage>
<pub-id pub-id-type="doi">10.1007/s13238-012-2078-6</pub-id>
<pub-id pub-id-type="pmid">23073833</pub-id>
</element-citation>
</ref>
<ref id="CR157">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paull</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sevilla</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Napolitano</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells</article-title>
<source/>Nat Methods
          <year>2015</year>
<volume>12</volume>
<fpage>885</fpage>
<lpage>892</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.3507</pub-id>
<pub-id pub-id-type="pmid">26237226</pub-id>
</element-citation>
</ref>
<ref id="CR158">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bock</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kiskinis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Verstappen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Boulting</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>ZD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines</article-title>
<source/>Cell
          <year>2011</year>
<volume>144</volume>
<fpage>439</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2010.12.032</pub-id>
<pub-id pub-id-type="pmid">21295703</pub-id>
</element-citation>
</ref>
<ref id="CR159">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dajani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>IH</given-names>
</name>
</person-group>
<article-title>Investigation of Rett syndrome using pluripotent stem cells</article-title>
<source/>J Cell Biochem
          <year>2013</year>
<volume>114</volume>
<fpage>2446</fpage>
<lpage>2453</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.24597</pub-id>
<pub-id pub-id-type="pmid">23744605</pub-id>
</element-citation>
</ref>
<ref id="CR160">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osafune</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Caron</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Borowiak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Fitz-Gerald</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Marked differences in differentiation propensity among human embryonic stem cell lines</article-title>
<source/>Nat Biotechnol
          <year>2008</year>
<volume>26</volume>
<fpage>313</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="doi">10.1038/nbt1383</pub-id>
<pub-id pub-id-type="pmid">18278034</pub-id>
</element-citation>
</ref>
<ref id="CR161">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gore</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Fung</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Antosiewicz-Bourget</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic coding mutations in human induced pluripotent stem cells</article-title>
<source/>Nature
          <year>2011</year>
<volume>471</volume>
<fpage>63</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1038/nature09805</pub-id>
<pub-id pub-id-type="pmid">21368825</pub-id>
</element-citation>
</ref>
<ref id="CR162">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussein</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Batada</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Vuoristo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ching</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Autio</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Narva</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy number variation and selection during reprogramming to pluripotency</article-title>
<source/>Nature
          <year>2011</year>
<volume>471</volume>
<fpage>58</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1038/nature09871</pub-id>
<pub-id pub-id-type="pmid">21368824</pub-id>
</element-citation>
</ref>
<ref id="CR163">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>QY</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>XY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mice generated from tetraploid complementation competent iPS cells show similar developmental features as those from ES cells but are prone to tumorigenesis</article-title>
<source/>Cell Res
          <year>2011</year>
<volume>21</volume>
<fpage>1634</fpage>
<lpage>1637</lpage>
<pub-id pub-id-type="doi">10.1038/cr.2011.143</pub-id>
<pub-id pub-id-type="pmid">21876560</pub-id>
</element-citation>
</ref>
<ref id="CR164">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>BY</given-names>
</name>
<name>
<surname>Weick</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>LX</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>XQ</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<fpage>4335</fpage>
<lpage>4340</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0910012107</pub-id>
<pub-id pub-id-type="pmid">20160098</pub-id>
</element-citation>
</ref>
<ref id="CR165">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srikanth</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Young-Pearse</surname>
<given-names>TL</given-names>
</name>
</person-group>
<article-title>Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells</article-title>
<source/>J Neurogenet
          <year>2014</year>
<volume>28</volume>
<fpage>5</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.3109/01677063.2014.881358</pub-id>
<pub-id pub-id-type="pmid">24628482</pub-id>
</element-citation>
</ref>
<ref id="CR166">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Muffat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Orlando</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Loven</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons</article-title>
<source/>Cell Stem Cell
          <year>2013</year>
<volume>13</volume>
<fpage>446</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2013.09.001</pub-id>
<pub-id pub-id-type="pmid">24094325</pub-id>
</element-citation>
</ref>
<ref id="CR167">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bershteyn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kriegstein</surname>
<given-names>AR</given-names>
</name>
</person-group>
<article-title>Cerebral Organoids in a Dish: Progress and Prospects</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<fpage>19</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.09.010</pub-id>
<pub-id pub-id-type="pmid">24074857</pub-id>
</element-citation>
</ref>
<ref id="CR168">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Smuga-Otto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Slukvin</surname>
<given-names>II</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human induced pluripotent stem cells free of vector and transgene sequences</article-title>
<source/>Science (New York, NY)
          <year>2009</year>
<volume>324</volume>
<fpage>797</fpage>
<lpage>801</lpage>
<pub-id pub-id-type="doi">10.1126/science.1172482</pub-id>
</element-citation>
</ref>
<ref id="CR169">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soldner</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Laganiere</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Hockemeyer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Alagappan</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations</article-title>
<source/>Cell
          <year>2011</year>
<volume>146</volume>
<fpage>318</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.06.019</pub-id>
<pub-id pub-id-type="pmid">21757228</pub-id>
</element-citation>
</ref>
<ref id="CR170">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papapetrou</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Sadelain</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector</article-title>
<source/>Nat Protoc
          <year>2011</year>
<volume>6</volume>
<fpage>1251</fpage>
<lpage>1273</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2011.374</pub-id>
<pub-id pub-id-type="pmid">21886095</pub-id>
</element-citation>
</ref>
<ref id="CR171">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Generation of induced pluripotent stem cells using recombinant proteins</article-title>
<source/>Cell Stem Cell
          <year>2009</year>
<volume>4</volume>
<fpage>381</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2009.04.005</pub-id>
<pub-id pub-id-type="pmid">19398399</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>